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Abstract 
Noble metal nanoparticles constitute promising biosensors due to a high and tailored affinity to 
biomolecules such as proteins, forming protein coronas of distinct compositions on the surface. Gold 
nanoparticles (AuNP) are particularly interesting for a relatively easy, quick and inexpensive synthesis, 
low toxicity and ease of functionalization with bifunctional molecules, which typically have thiol 
groups bound to the AuNP surface and bio-friendly chemical groups at the opposite end, allowing for 
controlled protein adsorption. Functionalized AuNP can be used as probing agents for blood samples 
and health states determined by the protein corona composition, which is divided into a strongly bound 
innermost hard corona and a looser external soft corona. 
The objective of this work was to further understand the behaviour of plasma proteins integrating 
the corona. To attain these objectives, conjugates were prepared with ca. 15 and 40 nm diameter AuNP 
and two important plasma proteins: serum albumin and fibrinogen. 
AuNP synthesis was by a modified Turkevich method, with diameter and concentration determined 
by UV-Vis spectroscopy. AuNP were functionalized with 11-mercaptoundecanoic acid and conjugated 
with bovine or human serum albumin or fibrinogen. These single protein conjugates were evaluated for 
colloidal stability with ionic strength and pH variation through UV-Vis, protein conformational changes 
through circular dichroism (CD), hydrodynamic diameter changes upon centrifugation through dynamic 
light scattering (DLS) and electrophoretic mobility and concentration dependent conjugation efficiency 
were determined through agarose gel electrophoresis (AGE). Analysis of AGE profiles was by the open 
source electrophoresis gel image processing software eReuss. 
CD confirmed α-helix loss for conjugated serum albumins. DLS showed a hydrodynamic diameter 
decrease for centrifuged 42 nm AuNP conjugates, with high polydispersity indexes for 13 nm ones, 
suggesting aggregation. AGE revealed electrophoretic mobility decreases as the protein:AuNP ratio 
increases, data fitted to a Langmuir adsorption model. 
Serum albumin undergoes conformational alterations upon conjugation with AuNP. Centrifugation 
affects the protein corona, despite its tendency to aggregate AuNP. Overall, CD, DLS and AGE were 
demonstrated as useful techniques for the characterisation of the protein corona. 
 
Keywords: Blood plasma proteins, protein corona, gold nanoparticles, circular dichroism, dynamic 
light scattering, electrophoresis  
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Resumo 
Nanopartículas de metais nobres constituem biossensores promissores devido a uma elevada e 
configurável afinidade para biomoléculas como proteínas, formando coroas proteicas de composições 
distintas à superfície. Nanopartículas de ouro (AuNP) são particularmente interessantes pela síntese 
relativamente fácil, rápida e económica, baixa toxicidade e facilidade de funcionalização com moléculas 
bifuncionais com grupos tiol ligados à superfície das AuNP e grupos químicos biocompatíveis na 
extremidade oposta, permitindo a adsorção controlada de proteínas. AuNP funcionalizadas podem ser 
usadas como sondas em amostras de sangue, sendo o estado de saúde determinado pela composição da 
coroa proteica, a qual é dividida numa hard corona interna fortemente ligada e numa soft corona externa 
fracamente ligada. 
O objetivo deste trabalho foi melhorar a compreensão do comportamento das proteínas do plasma 
integrando a corona. Para atingir este objetivo, conjugados foram preparados com AuNP de ca. 15 e 40 
nm de diâmetro e duas importantes proteínas do plasma: albumina do soro e fibrinogénio. 
A síntese das AuNP seguiu um método de Turkevich modificado, sendo o diâmetro e concentração 
determinados através de UV-Vis. As AuNP foram funcionalizadas com ácido 11-mercaptoundecanóico 
e conjugadas com albumina do soro ou fibrinogénio bovinos ou humanos. Conjugados foram avaliados 
pela estabilidade coloidal variando força iónica ou pH por UV-Vis, pelas modificações conformacionais 
nas proteínas por dicroísmo circular (CD), pela diferença no diâmetro hidrodinâmico após centrifugação 
por dispersão dinâmica de luz (DLS) e a mobilidade eletroforética e eficácia de conjugação dependente 
da concentração determinadas por eletroforese em gel de agarose (AGE), cujos perfis foram analisados 
pelo programa eReuss. 
CD confirmou perda de α-hélices em conjugados de albumina do soro. DLS apresentou um 
decréscimo no diâmetro hidrodinâmico de conjugados de AuNP de 42 nm centrifugados, com altos 
índices de polidispersidade nos de 13 nm, sugerindo agregação. AGE revelou que a mobilidade 
eletroforética diminui com o aumento da razão proteína:AuNP, dados ajustados a um modelo de 
adsorção de Langmuir. 
A albumina do soro sofre alterações conformacionais após conjugação com AuNP. A 
centrifugação afeta a coroa proteica, apesar da tendência para agregar AuNP. CD, DLS e AGE foram 
demonstradas como sendo técnicas úteis para a caracterização da coroa proteica. 
 
Termos chave: Proteínas do plasma sanguíneo, coroa proteica, nanopartículas de ouro, dicroísmo 
circular, dispersão dinâmica de luz, eletroforese  
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1 Introduction 
1.1 Blood proteins 
Blood is amongst the most abundant body fluids in animals, acting as the main transportation 
network in the entire organism, reaching out to deliver nutrients and oxygen to all cells whilst collecting 
metabolic waste products for disposal, as well as a vehicle for immune response and wound sealing and 
a body temperature regulator. It can be fractioned into a solid and a liquid phase. The former comprises 
the blood cells and makes up approximately 45% of its total volume, most of which being erythrocytes, 
with leukocytes and platelets falling under < 1%, although the erythrocyte volume percentage – known 
as the haematocrit – varies according to some factors such as gender, with normal values ranging from 
42% to 52% in males and from 37% to 47% in females. Despite the proteins found on blood cells, such 
as haemoglobin, the majority of all blood proteins are contained in the blood plasma – the liquid phase 
making up the remaining approximate 55% of the total blood volume. At 7% of the total blood plasma 
volume, the hundreds of different types of blood plasma proteins represent its major constituents besides 
water, which makes up 92% of plasma. These free circulating blood plasma proteins can be categorised 
into three groups – albumin, globulins and fibrinogen (table 1.1).1–3 
 
Table 1.1. Blood plasma constituents. Adapted from 1. 
Plasma constituent 
and abundance 
Constituent type 
and abundance 
Production site Major function(s) 
Water 
92% 
Fluid 
Absorbed in intestine; 
metabolised 
Transport medium 
Plasma proteins 
7% 
Albumin 
54-60% 
Liver 
Transport; maintain 
osmotic concentration 
Globulins 
35-38% 
α-globulins – liver 
Transport; maintain 
osmotic concentration 
β-globulins – liver 
Transport; maintain 
osmotic concentration 
γ-globulins – plasma 
cells 
Immune response 
Fibrinogen 
4-7% 
Liver 
Blood clotting in 
haemostasis 
Regulatory proteins 
< 1% 
Hormones and 
enzymes 
Various sources 
Regulate various body 
functions 
Other solutes 
1% 
Nutrients, gases and 
wastes 
Various sources 
 
 
 
 
 
Numerous and varied 
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As blood flows throughout the organism, it suffers alterations to its plasma protein concentrations 
when passing through diseased cells or tissues. By completely characterising how the plasma protein 
profile of a healthy individual changes in accordance to natural factors, such as genetic background, 
age, disease history and life style, it is possible to define a baseline against which diseased plasma 
protein profiles can be compared in order to define disease states.4–8 The present work focused on 
albumin and fibrinogen. 
 
1.1.1 Serum albumin 
The most abundant protein in blood plasma, serum albumin is a monomeric globular protein of 
approximately 67 kDa, which is produced in the liver and acts as a versatile transportation protein, being 
capable of binding to and carrying along the bloodstream hydrophobic biomolecules, such as fatty acids, 
as well as hormones and even certain drugs. It is comprised of three homologous domains (I, II and III), 
each divided into two sub-domains named A and B, of six and four α-helices, respectively. Hydrophobic 
pockets in the sub-domains IIA and IIIA – designated Sudlow’s sites I and II, respectively – are known 
binding points for some ligands, such as drugs. Structurally, serum albumin consists of 67% α-helices, 
with the remainder being random coils, stabilised by 17 internal disulphide bridges between 34 cysteine 
residues into an equilateral triangle shape (figure 1.1), which it retains under a pH range from 4.5 to 8.0 
and beyond which this natural shape unfolds. In aged protein solutions, serum albumin dimers may 
sometimes form through the free Cys-34 thiol group.9–14 
 
 
Figure 1.1. Structural representation of human serum albumin and its domains, sub-domains and Sudlow’s binding 
sites I and II.9 
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1.1.2 Fibrinogen 
Despite being the least abundant of the three blood plasma protein groups, comprising 4-7% of 
all plasma proteins1, fibrinogen is a rather individually abundant protein in blood, at 3 mg/mL15; and an 
essential factor to the coagulation cascade and a unique and vital protein in the organism, its presence 
or absence differentiating between plasma and serum, respectively. A rod-shaped glycoprotein of 
approximately 340 kDa produced in the liver, fibrinogen is composed of three symmetrical pairs of 
polypeptide chains, designated Αα, Ββ and γ, which are held together by disulphide bridges and mainly 
comprised of coiled coils extended linearly, with three distinct globular domains formed at the chain 
termini regions. A central domain (E) contains the termini of all three pairs of chains, whilst at the two 
distal domains, located on both extremities of the molecule (D), are the C-termini of the Ββ and γ chains. 
In response to injury, fibrinogen, a soluble protein, is cleaved by the serine protease thrombin into 
insoluble fibrin monomers, which polymerise into fibrils and subsequently branch to form a clot (figure 
1.2).15–20 
 
 
Figure 1.2. Structural representation of human fibrinogen and its Αα (blue), Ββ (green) and γ (red) chains (A) and 
a depiction of the fibrin polymerisation process through the cleavage of fibrinopeptides by thrombin (B).15  
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The C-termini of the Αα chains are typically associated with the E domain through non-covalent 
interactions, although these chains are known to suffer conformational alterations depending on solution 
conditions such as pH or ionic strength, further changing the shape of the fibrinogen molecule beyond 
its already inherent flexibility. Under physiological conditions, including a pH = 7.4 – that of healthy 
blood – fibrinogen is mostly found in a semi-collapsed conformation, as the electrostatic potential at 
the E domain becomes negatively charged, causing an electrostatic attraction of the positively charged 
C-termini of the Αα chains (figure 1.3).21 
 
 
Figure 1.3. Predicted fibrinogen conformations depending on solution conditions. Adapted from 21. 
 
1.2 Gold nanoparticles 
Nanoparticles of various compositions and shapes can and have been utilised in studies resorting 
to the characterisation of a protein corona formed from blood plasma proteins in order to define diseases 
and states thereof.22–25 The present work focused on spherical gold nanoparticles (AuNP) and further 
exploited the potential and interesting properties of the AuNP for diagnostic purposes. 
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AuNP consist of structures made of elemental gold in a size range of 1-100 nanometres, in which 
nanotechnological and biomedical interest has grown in recent years due to an easy and quick synthesis 
and the unique and exploitable physicochemical and optical properties gold possesses at the nanoscale. 
AuNP retain great stability whilst also showing high versatility, with possible applications ranging from 
imaging, sensing, assisted drug delivery or cancer therapy. The ease of imparting functionality to these 
nanoparticles with different functionalization molecules contributes to this versatility. Moreover, these 
nanostructures also present relatively low cytotoxicity, making AuNP excellent candidates for in vivo 
applications, which complement the high accessibility to biological cells or tissues inherent to particles 
this small.26–31 
In any metal surface of small dimensions, incident light excites the free electrons of metal atoms 
at the media interface into oscillating in resonance with its electric field. Such free electron oscillations 
are collectively denominated a plasmon (plasma + boson), since the negatively charged electron clouds 
are displaced from the respective equilibrium position at a lattice of positively charged ions – as occurs 
in plasma – and oscillate at a quite precise frequency, classifying as a bosonic quasi-particle excitation. 
This effect is known as surface plasmon resonance (SPR) and causes the absorption of incident light at 
specific wavelengths, unique for each surface of different compositions, sizes or surface modifications. 
However, this phenomenon does not occur in bulk metal, as the plasmon and photon energy dispersion 
curves never intersect in the internal atoms. Should the plasmons be confined to a structure smaller than 
the wavelength of the incident light, such as a nanoparticle, then the SPR is said to be localised (LSPR) 
(figure 1.4). 
 
 
Figure 1.4. The electric field of incident light induces the SPR phenomenon on a metal surface (A) or its localised 
variant, LSPR if the surface plasmons are confined to a structure smaller than the wavelength of the incident light 
(B), such as nanoparticles. Adapted from 32. 
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In the case of monodisperse 15 nm AuNP, for example, the LSPR effect causes the absorption of 
light at a wavelength of approximately 520 nm, whilst red light is entirely reflected, hence the red colour 
characteristic to colloidal gold suspensions. Certain alterations to the absorption spectrum convey much 
information regarding the nanoparticles in study. For instance, shifts in the absorption peak can indicate 
the adsorption of some substance to the surface of the nanoparticle, changing the refractive index of the 
immediate medium surrounding it and thus altering the wavelengths affected by the LSPR. Other effects 
include an increased absorption spectrum width or having more than one absorption peak, which are all 
indicative of polydispersity and due to the LSPR coupling of nanoparticle populations of different sizes. 
Furthermore, larger nanoparticles absorb light with more intensity than smaller ones (figure 1.5).32–36 
 
 
Figure 1.5. Some exploitable LSPR alterations on plasmonic nanoparticles include refractive index change based 
on surface composition, signal coupling characteristic to nanoparticle aggregation or signal amplification with the 
increase of nanoparticle size. Adapted from 34.  
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1.2.1 Synthesis 
AuNP can be synthesised through various methods, some based on a top-down approach, others 
on a bottom-up chemical reaction, namely the reduction of a gold salt. The synthesis method determines 
the shape and size of the AuNP. For this work, the simple bottom-up chemical approach first described 
by Turkevich et al. was used, which relies on chloroauric acid (HAuCl4) as a gold precursor and sodium 
citrate (Na3C6H5O7) as a reducing agent, both heated in an aqueous solution, in which several reactions 
occur in parallel, the first in a sequence being the oxidation of citrate into dicarboxy acetone, promoting 
the reduction of auric salt into aurous salt, which subsequently disproportionates to gold atoms: 
 
 𝐶6𝐻5𝑂7
3− → 𝐶5𝐻4𝑂5
2− + 𝐶𝑂2 + 𝐻
+ + 2𝑒− Equation 1.1 
 
 𝐴𝑢𝐶𝑙3 + 2𝑒
− → 𝐴𝑢𝐶𝑙 + 2𝐶𝑙− Equation 1.2 
 
 3𝐴𝑢𝐶𝑙 → 2𝐴𝑢0 + 𝐴𝑢𝐶𝑙3 Equation 1.3 
 
As the concentration of disproportionated gold atoms increases, these aggregate to form nuclei 
which grow by absorbing further gold atoms produced by disproportionation (figure 1.6). 
 
 
Figure 1.6. Synthesis of AuNP through citrate reduction.37  
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Sodium citrate acts as the reducing agent as well as a capping agent which stabilises the surface 
of the AuNP during the growth phase. Thus, by altering its concentration, it is possible to adjust the size 
of synthesised nanoparticles, since having less citrate present results in fewer ions to stabilise the surface 
of the AuNP, allowing these to grow larger.37–40 Additionally, the order in which the gold precursor and 
the reducing agent are added to the reaction affects the polydispersity of AuNP. Whilst Turkevich et al. 
added sodium citrate to a heated chloroauric acid solution, which became known as the “direct method”; 
the reverse order, or the “reverse method”, has been observed to yield less polydisperse nanoparticles, 
since heating the sodium citrate prior to adding the chloroauric acid ensures its partial oxidation before 
coming into contact with the gold salt, therefore substantially increasing the nucleation and growth rates 
and greatly narrowing the size distribution (figure 1.7).41 
 
 
Figure 1.7. Transmission electron microscopy (TEM) morphological characterisation of AuNP synthesised using 
the direct and inverse methods with two citrate:HAuCl4 ratios. Size distribution is represented in the inset graphs.41 
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1.2.2 Electric double layer 
Nanoparticles can be found in the form of colloids – solid particles suspended in a continuous 
liquid – and, as such, can acquire the electric charge of adsorbed ions found in the colloidal suspension 
and attract counterions of an opposite charge, forming what is known as the electric double layer (EDL). 
At the closest proximity to the surface of the nanoparticle, the Stern layer is exclusively composed of 
counterions – therefore possessing the maximum electric potential – and is delimited by the Stern plane, 
beyond which begins the diffuse layer, comprised of counterions as well as ions of an identical charge 
to that imparted to the nanoparticle (figure 1.8). The electric potential is inversely proportional to the 
distance from the nanoparticle surface, becoming null at the edge of the EDL. As a nanoparticle diffuses 
through the colloid, a layer of the surrounding liquid becomes attached to its surface due to electrostatic 
forces derived from the EDL. The boundary between these captured molecules and the free ones is the 
slipping plane, located in the diffuse layer. The electric potential at the slipping plane is the ζ-potential 
(zeta potential) and is the only measurable value in the electric potential of a colloid.42–44 
 
 
Figure 1.8. The electric double layer on a spherical particle with the electrical potential curve for each plane.42  
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In studies involving colloids, it is important to consider colloidal stability, which is explained 
by the DLVO theory – named after Derjaguin, Landau, Verwey and Overbeek – as the balance between 
the Coulombic or electrostatic repulsions and the van der Waals attractions amongst identically charged 
suspended particles. Therefore, the colloidal stability of nanoparticles of different compositions can be 
determined by the total interaction energy between two approaching particles (VT) in function of the 
distance separating both (x), which is given as the sum of the van der Waals attractive potential energy 
(VA) and the EDL repulsive potential energy (VR), at that distance: 
 
 𝑉𝑇(𝑥) = 𝑉𝐴(𝑥) + 𝑉𝑅(𝑥) Equation 1.4 
 
 𝑉𝐴(𝑥) = −
𝐴𝑟
12𝑥
 Equation 1.5 
 
 𝑉𝑅(𝑥) = 2𝜋𝜀𝑟𝜀0𝑟𝜁
2𝑒−𝜅𝑥 Equation 1.6 
 
A is the Hamaker constant, r the radius of the particles, εr the medium relative permittivity, ε0 
the vacuum permittivity, ζ the ζ-potential, e the elementary charge and κ the Debye-Hückel parameter, 
the reciprocal of which is known as the Debye length and represents the thickness of the EDL: 
 
 𝜅−1 = √
𝜀𝑟𝜀0𝑘𝐵𝑇
2𝑒2𝐼
 Equation 1.7 
 
kB is the Boltzmann constant, T the temperature and I the ionic strength of the electrolytes. This 
also demonstrates how the electrolyte concentration affects the thickness of the EDL and, consequently, 
the ζ-potential. 
As two identically charged colloidal particles approach, the total interaction energy tends from 
null to predominantly repulsive – the primary maximum – beyond which, at even shorter distances, the 
van der Waals attraction overcomes the EDL electrostatic repulsion – the primary minimum – and both 
particles become irreversibly aggregated. However, if the concentration of counterions is high enough, 
a secondary minimum appears at a slightly longer distance than that of the primary maximum, at which 
the particles undergo a weak and reversible aggregation designated flocculation (figure 1.9).42,45,46 
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Figure 1.9. Total interaction energy between two colloidal particles in dependence of the separation distance, as 
per the DLVO theory. Adapted from 47. 
 
Both the EDL electrostatic repulsions and van der Waals attractions amongst colloidal particles 
greatly depend on the distance between these. However, the attractive interactions are also proportional 
to particle size, being weaker on smaller particles, which are therefore more stable.48 On the other hand, 
the EDL electrostatic repulsions are influenced by its thickness and the ζ-potential, which, as previously 
mentioned, are both affected by the electrolyte concentration. Monovalent salts, for example, can induce 
a momentary dipole, which weakens the repulsion of suspended particles.42 The minimum concentration 
of counterions required for the aggregation of colloidal particles is denominated the critical coagulation 
concentration (CCC).49,50 Moreover, the ζ-potential becomes virtually null at a colloid pH equal to the 
pI of the nanoparticles, as it reaches the point of zero charge and repulsive forces cease, which means 
these are most unstable and possess a high tendency to aggregate.51 Alterations in the microenvironment 
such as increased ionic strength or lowered pH not only impact the stability of nanoparticles, but might 
also cause the desorption of proteins contained in the protein corona.52 
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1.2.3 Functionalization 
Citrate binds to the surface of AuNP through physisorption, by weak and easily disrupted van 
der Waals interactions. In order to impart greater stability – thus avoiding aggregation – and introduce 
tailored functionality, AuNP are typically exposed to molecules with a higher affinity to the surface of 
these nanoparticles, such as thiolates, as the sulphur atom in the thiol group binds through chemisorption 
to the gold atoms53 and effectively replaces citrate as a capping agent. These thiolated functionalization 
molecules include a terminal group opposite to the thiol group, which determines the surface chemistry 
and charge of the AuNP and through which molecules such as proteins adsorb to the nanoparticle, with 
the functionalization agent as an intermediate. A hydrophobic spacer exists between the thiol group and 
the functionalizing group, which promotes the formation of a self-assembled monolayer (SAM) of 
capping agent fully covering the surface of AuNP. For this work, 11-mercaptoundecanoic acid (MUA) 
was used as a capping agent, which possesses a carboxylic group at the functionalizing end, imparting 
AuNP with a negative surface charge and allowing for the electrostatic binding to the positively charged 
regions of the studied proteins (figure 1.10).54,55 Furthermore, AuNP with a negatively charged surface 
have been demonstrated to exhibit less cytotoxicity than positively charged ones, therefore being more 
advantageous for in vivo diagnostics applications.56 
 
 
Figure 1.10. Structural representation of 11-mercaptoundecanoic acid. Molecule image generated with PubChem. 
 
1.2.4 Conjugation 
As diffusing proteins and capped AuNP come into contact, an initial adsorption depends on the 
electrostatic attraction forces between the charged surface of the nanoparticles and the amino acids with 
the opposite charge on the protein. Upon first contact, proteins remain adsorbed to the AuNP primarily 
through van der Waals forces, although hydrogen bonds can also occur between the proteins and AuNP 
capping molecules, as well as acid-base adducts, dipole-dipole interactions or London dispersion forces. 
Once adsorbed, proteins replace the ions and water molecules on the AuNP surface, whereas the AuNP 
occupy the protein solvent shell.23 
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The adsorption of proteins to a capped AuNP directly affects its electrophoretic mobility, as the 
surface charge of the nanoparticle is reduced. Furthermore, electrophoretic mobility variations can also 
be related to the degree of protein coverage the AuNP exhibits.23 The electrophoretic mobility difference 
between unconjugated AuNP and AuNP with increasing single protein coverage degrees has been found 
to fit the Langmuir adsorption model.11,22,23,57 This model fundamentally assumes proteins behave as an 
ideal gas at isothermal conditions and defines the loss of electrophoretic mobility as proportional to the 
occupancy of the AuNP surface, which depends on the free protein concentration and a thermodynamic 
equilibrium constant. Additionally, proteins are assumed to bind to definite surface sites, with each site 
having the capacity for one protein only; and also that the binding energy for each protein is independent 
of steric hindrance caused by proteins adsorbed to neighbouring sites.58 One limitation to approximating 
AuNP-protein conjugation to this model is that the free protein concentration is assumed as equal to the 
initial protein concentration, whereas, in reality, the free protein concentration decreases over time as it 
is adsorbed to the surface of AuNP. This becomes increasingly more pronounced at lower initial protein 
concentrations. Another problem arises with the assumption of a linear proportionality between the loss 
of electrophoretic mobility and the occupancy of the AuNP surface, implying a constant electrophoretic 
mobility loss for increasing amounts of protein. In reality, as it has been empirically observed11,22,23, the 
electrophoretic mobility loss decreases as more protein is adsorbed to the surface of the AuNP. Despite 
this, the Langmuir adsorption model has seen extensive use to study protein adsorption phenomena.57 
 
1.3 Protein corona 
The previously mentioned characterisation of plasma protein profiles pertaining to healthy and 
diseased individuals is a continuing study which has been performed based on the adsorption of these 
proteins to specific surfaces – typically nanomaterials, such as nanoparticles – upon exposure to blood 
samples.7,8,22,59 These protein-surface interactions rely on van der Waals forces as well as the contact 
between charged amino acids – which are hydrophilic and therefore located externally on the protein – 
and the charged surface; and can be of geometric, chemical and/or electrical nature.52 Numerous factors 
pertaining to the proteins, the surface and the medium influence these interactions. For instance, larger 
proteins, more elongated, unstable or with higher unfolding rates possess a greater number of contact 
points in the same way more textured surfaces have a broader surface area.52 
Moreover, the adsorption of proteins to a surface begins as a fast electrostatic binding, yet in time 
slow protein rearrangements can occur, ranging from orientation shifts (figure 1.11) to conformational 
alterations, in order to present the most contact points to the surface.23 
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Figure 1.11. Possible orientations of a prolate ellipsoid protein bound to the surface of a spherical nanoparticle.23 
 
Positively charged proteins adsorb more strongly to a negatively charged surface and vice-versa. 
However, lateral repulsions between proteins of identical charge can hinder further adsorption as more 
proteins accumulate at the surface. Because of this, protein-surface interactions are maximised at a pH 
closer to the pI of the protein, since its net surface charge is nearly neutral. This also points out to the 
importance of microenvironmental factors of the medium, such as pH. 
Furthermore, proteins might also undergo conformational alterations in response to medium pH, 
temperature or ionic strength, as well as a consequence of being adsorbed to a surface, thus exposing 
different binding points to it. This can be influenced by the bulk protein concentration (figure 1.12) and 
greatly depends on the different stability constants.52 
 
 
Figure 1.12. Proteins undergo conformational alterations depending on bulk protein concentration (left) or surface 
exposure time (right). Adapted from 52.  
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In a suspension, such as a blood sample, proteins are subject to diffusion, through which these 
come into contact with the surface. The diffusion rate can be described by equation 1.8: 
 
 
𝛿𝑐
𝛿𝑡
= 𝐷
𝛿2𝑐
𝛿𝑥2
 Equation 1.8 
 
c is the protein concentration, t the time, D the diffusion coefficient and x the distance the protein 
travelled to reach the surface. Assuming short times and an equivalence between the rates of diffusion 
and of adsorption, this can be simplified to equation 1.9: 
 
 
d𝑛
d𝑡
= 𝑐0√
𝐷
𝜋𝑡
 Equation 1.9 
 
n is the protein concentration at the surface and c0 the bulk protein concentration. This shows that 
the protein adsorption efficiency is directly proportional to its bulk concentration as well as the diffusion 
coefficient. 
In fact, an interesting phenomenon has been documented whereby the composition of the protein 
coating of a surface exposed to a blood sample varies with time. The most abundant or smaller proteins 
– therefore with higher diffusion coefficients – adsorb first, only to be gradually replaced by others with 
greater affinity to the surface, which either exist in the plasma at a lower concentration, possess a lower 
diffusion coefficient, or both. This is known as the Vroman effect.52,59,60 The rate at which the diffusing 
plasma proteins arrive at a surface can be derived from equation 1.9 and given as c0√D (table 1.2).60 
 
Table 1.2. Rate of arrival of the twelve most abundant plasma proteins at a surface based exclusively on diffusion. 
Adapted from 60. 
Protein c (µM) D (10-7 cm2s-1) 𝒄𝟎√𝐃 
Albumin 600 6.1 1500 
IgG 100 4.0 200 
α1-antitrypsin 40 5.2 91 
Transferrin 30 5.0 67 
α2-haptoglobins 20 4.7 43 
IgA 18 4.6 39 
HDL 15 4.0 30 
Complement 3 9 4.5 19 
Fibrinogen 7.5 2.0 11 
α2-macroglobulin 3.3 2.4 5 
LDL 2 2.0 3 
IgM 1 2.6 1.6 
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Nanoparticles of various compositions and shapes have seen extensive use as surfaces onto which 
plasma proteins adsorb for subsequent profiling7,8,61,62, the most common shape being the sphere, since 
it is easier to synthesise and possesses an isotropic surface charge distribution63,64. The protein coating 
enveloping these spherical nanostructures is denominated the protein corona, which behaves much like 
the previously discussed EDL and is divided into two layers: the hard corona and the soft corona (figure 
1.13). The hard corona corresponds to the innermost monolayer, composed of proteins with the highest 
affinity to the nanoparticle over the exposure time, as per the Vroman effect, which bind directly to the 
surface of the nanoparticle. Protein exchange rates with the immediate microenvironment are minimal 
at this layer and adsorption is practically irreversible, as proteins are displaced exclusively by others of 
higher affinity. The soft corona, on the other hand, designates the collective outer layers, which establish 
protein-protein interactions with the hard corona as well as mutually, thus making the soft corona more 
loosely adsorbed, so much that mechanical methods such as centrifugation are typically used to separate 
it from the nanoparticle-protein complex. At this layer, protein adsorption is reversible and the exchange 
rates are comparatively much higher.7,8,24,59,61,62,65 
 
 
Figure 1.13. Composition of a protein corona formed on a spherical nanoparticle upon exposure to blood (A) and 
after some exposure time (B). Adapted from 59. 
 
Previous studies7,8 have exploited the protein corona and successfully demonstrated a correlation 
between individual protein coronas profiles and specific diseases (figures 1.14 and 1.15). 
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Figure 1.14. Relative intensity of silver stained SDS-PAGE protein bands pertaining to polystyrene nanoparticles 
incubated with plasma (50%) from different patients. Adapted from 7. 
 
 
Figure 1.15. Different protein hard coronas are formed on nanoparticles exposed to a blood sample depending on 
several diseases or medical conditions.7 
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1.4 Toxicology concerns 
As AuNP can potentially be employed in various in vivo nanomedical applications in the future, 
some considerations must be addressed, namely the health risks. Despite virtually no cytotoxicity being 
reported for these nanoparticles, the long-term effects of exposure are still being evaluated. The protein 
corona formed through the conjugation of plasma proteins with AuNP introduced into the bloodstream 
enhances biocompatibility and dissimulates the nanoparticles to leukocytes and macrophages, avoiding 
an immune response for a time. Yet, depending on the protein corona composition, an immune response 
can be suppressed just as well as it can be triggered. Moreover, previous studies have determined AuNP 
larger than 40 nm in diameter are extremely prone to opsonisation, becoming marked for phagocytosis. 
Conversely, AuNP of smaller sizes also present higher colloidal stability, albeit having a poorer protein 
coating, hence the maximum AuNP diameter utilised in this work was 40 nm.25,66–68 
19 
 
2 Objectives 
The application of gold nanoparticles in theragnostics, despite promising, must yet undergo further 
study in order to assess possible health risks and fully understand the mechanics behind the interactions 
between these nanoparticles and biomolecules, allowing for the design of novel biomedical techniques. 
The approach herein presented describes the implementation of spherical gold nanoparticles as probing 
matrixes onto which blood plasma proteins adsorb once exposed to a blood sample, functioning in vivo 
just as well as ex vivo – thus eliminating the health risks – and based on the premise that diseases cause 
fluctuations on plasma protein gradients, as already determined in previous studies. These gradients are 
unique for each disease and, as such, translate into unique plasma protein coronas formed on the surface 
of gold nanoparticles, the characterisation of which is key to profile specific protein coronas associated 
to the respective diseases and states thereof. However, before a comprehensive protein corona profiling 
can be elaborated, the adsorption mechanism of each plasma protein to gold nanoparticles must first be 
better understood. 
This is a continuing work which has been previously performed on two important plasma proteins, 
serum albumin and fibrinogen, both of bovine origin. In the present work, these proteins were compared 
to the respective human counterparts, either sequentially, structurally and in the empirical evaluation of 
the conjugates formed with gold nanoparticles, considering the ultimate purpose is the design of a novel 
technique for the diagnosis of human diseases. 
The colloidal stability of gold nanoparticle conjugates with each studied protein relative to the bare 
nanoparticles was compared under different ionic strength and pH conditions. 
Conformational alterations of proteins adsorbed to the surface of gold nanoparticles were evaluated 
through circular dichroism spectroscopy. 
The protein corona was studied through a comparative measurement of the hydrodynamic diameter 
of the soft and hard coronas formed of each studied protein on gold nanoparticles of two different sizes, 
using dynamic light scattering. 
The molar ratio of each studied protein to a gold nanoparticle necessary to completely cover it was 
determined by agarose gel electrophoresis, in which conjugation curves could be visualised and through 
which the binding constants for each protein could be estimated. 
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3 Methods 
All reagents and instruments are documented in Appendix II. 
 
3.1 Synthesis of spherical gold nanoparticles 
All glassware utilised throughout the experiments to contain AuNP and AuNP conjugates was 
previously washed with aqua regia – a mixture of nitric acid (HNO3) and hydrochloric acid (HCl) in a 
molar ratio of 3:1, respectively – which quickly dissolves any metallic residue, following successive 
rinses with Milli-Q water (18.2 MΩ·cm at 25 °C) until a pH of 7.0, as measured with pH test strips. 
The synthesis of spherical AuNP was achieved through the method first described by Turkevich 
et al.69, with some minor modifications by Kimling et al.70, in which sodium citrate tribasic dihydrate 
(Na3C6H5O7·2H2O) acts as both a reducing agent to chloroauric acid (HAuCl4), thus generating the Au0 
atoms required for nucleation; and a primary capping agent to control nanoparticle growth and impede 
contact-induced aggregation. Chloroauric acid was added to a boiling sodium citrate solution, following 
the “reverse method” discussed by Ojea-Jiménez et al.41, as it has been demonstrated to yield much less 
polydisperse AuNP. This reaction occurred in a round bottom flask under constant heating, magnetic 
stirring and reflux, as to avoid losing volume by evaporation, with subsequent concentration changes. 
 
3.1.1 Synthesis of spherical gold nanoparticles with ca. 15 nm diameter 
98 mL of Milli-Q water were heated until boiling, after which 2 mL of sodium citrate (343 mM) 
were added. After 5 minutes, 69.2 µL of chloroauric acid (1.42 M) were added. It is at this stage that 
the solution acquires an immediate dark colour, which gradually subsides to dark red. After another 5 
minutes, the reaction was stopped, heating, stirring and reflux turned off; and the colloidal suspension 
was cooled to room temperature (25 ºC) for a few hours, before filtering through a disk filter (0.20 µm 
pore size) adapted to a syringe. This filtration step is to remove large aggregates in the obtained colloidal 
suspension and maintain polydispersity as low as possible. This method has yielded spherical AuNP of 
10-15 nm in diameter, as determined by a method developed by Haiss et al.71 (see below in section 3.2). 
 
3.1.2 Synthesis of spherical gold nanoparticles with ca. 40 nm diameter 
This protocol was based on the one kindly provided by Miguel Peixoto de Almeida, PhD, from 
Prof. Eulália Pereira’s research group at LAQV, REQUIMTE, Faculdade de Ciências, Universidade do 
Porto, Portugal. 150 mL of sodium citrate (2.2 mM) were heated until boiling, with 1 mL of a 25 mM 
chloroauric acid solution added thereafter. After 10 minutes, the reaction was cooled to 90 ºC and 1 mL 
of the 25 mM chloroauric acid solution was added to the gold seeds; and again after 30 minutes. After 
another 30 minutes, the reaction was stopped and proceeded similarly to the method described above, 
for the synthesis of smaller AuNP. This method has yielded spherical AuNP of 40-45 nm in diameter, 
as determined by a method developed by Haiss et al.71 (see below in section 3.2). 
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All colloidal suspensions of AuNP were stored in glass recipients covered with aluminium foil, 
in order to avoid light exposure which may induce nanoparticle aggregation; and kept at 4º C until used. 
pH of the as-synthesised solutions was 6.5. Note that AuNP-citrate become increasingly unstable with 
more acidic pH (< 7)72, reaching a maximum point of aggregation at a pH of approximately 3.73 This is 
due to citrate becoming completely protonated at lower pH, therefore reducing the number of negative 
surface charges, which promotes the attraction forces amongst AuNP.72 
 
3.2 Gold nanoparticle characterisation 
Through an empirical UV-Vis spectroscopy method discussed by Haiss et al.71, it was possible 
to calculate the diameter and concentration of spherical AuNP-citrate utilising the LSPR effect and the 
molar extinction coefficient, respectively. This method cannot be applied to spherical AuNP larger than 
100 nm or smaller than 2 nm in diameter, or to non-spherical AuNP or functionalized with other capping 
agents. 
Triplicate UV-Vis spectra in a 750-350 nm wavelength range were taken from 1:2 dilutions of 
the AuNP-citrate colloidal suspension. 
To estimate the diameter of the AuNP with an expected size of < 35 nm, the absorbance at the 
LSPR peak (ALSPR) and at 450 nm (A450 nm) were required for the following equation: 
 
 ⌀ = exp (
𝐴𝐿𝑆𝑃𝑅
𝐴450 𝑛𝑚
− 𝑏
𝑚
) Equation 3.1 
 
m and b represent the slope and intercept, respectively, of the equation fitted to the plotted tabular 
values of the ALSPR/A450 nm ratio against the respective AuNP diameter, in nm, presented by Haiss et al.71 
(Appendix III).  
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Figure 3.1. The ratio of the absorbance at the LSPR peak to the absorbance at 450 nm in dependence of the natural 
logarithm of AuNP diameter, in nm, can be fitted to the linear equation shown above, with an R2 > 0.999. 
 
For AuNP with an expected size of > 35 nm, a different equation was used, which requires only 
the wavelength at the LSPR peak: 
 
 ⌀ =
ln (
𝜆𝐿𝑆𝑃𝑅 − 512
6.53 )
0.0216
 Equation 3.2 
 
Once the AuNP diameter was known, the concentration was estimated through the Beer-Lambert 
law by correlating the absorbance at 450 nm with the respective molar extinction coefficient (the value 
of which corresponds to a specific diameter, see Appendix II): 
 
 𝐴450 𝑛𝑚 = 𝜀450 𝑛𝑚𝑙𝑐 Equation 3.3 
 
ε is the molar extinction coefficient (M-1 cm-1), l the optical path (cm) and c the concentration of 
the diluted AuNP colloidal suspension (M), which were then multiplied by the dilution factor (1:2). 
 
3.3 Gold nanoparticle functionalization 
AuNP-citrate were functionalized with 11-mercaptoundecanoic acid (MUA) – a thiol-containing 
molecule which replaces the electrostatically bound citrate from the surface of AuNP, imparting these 
with a negative surface charge and a much higher colloidal stability. In fact, samples of AuNP-citrate 
tend to aggregate irreversibly after centrifugation, even at low speeds, or in agarose gel electrophoretic 
assays. 
A stable solution of MUA 0.01 M was prepared by solubilising 21.8 mg of MUA in 10 mL 
absolute ethanol (HPLC grade). 
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The colloidal suspensions of AuNP-citrate were diluted in Milli-Q water to the intended final 
concentration of the AuNP-MUA stock solution. Basic water should be avoided, as it tends to induce 
irreversible AuNP aggregation due to the ionic strength imparted by the salt used to basify the water. 
A volume of the MUA 0.01 M solution was added to the AuNP-citrate colloidal suspension for 
a MUA:AuNP molar ratio experimentally determined to be sufficient for a full coverage of the surface 
of AuNP (5000:1 for the ca. 15 nm AuNP and 15000:1 for the ca. 40 nm AuNP), under magnetic stirring 
for 15 minutes, after which it was incubated overnight at room temperature, thus ensuring a complete 
MUA monolayer formation. Any excess, unbound MUA was removed through centrifugation (9520 g 
for 10 minutes). AuNP concentrations greater than 5 nM have been observed to possess a high tendency 
to aggregate from the centrifugation, most probably due to the greater steric proximity amongst AuNP 
in the resulting pellet. A successful functionalization can be assessed by UV-Vis spectroscopy, in which 
the absorbance in the 750-600 nm wavelength range – a region in which high absorbance indicates the 
presence of aggregates – should be as low as possible, whilst a slight redshift (≈ 5 nm) of the LSPR 
peak, compared to the AuNP-citrate spectra, should be observed. 
 
3.4 Protein preparation 
All studied proteins were solubilised in potassium phosphate buffer 5 mM, pH 7.4. This 
apparently low ionic strength is just enough to ensure protein solubilisation and stability, whilst 
avoiding AuNP aggregation induced by ionic strength. This buffer was prepared by dilution in Milli-Q 
water of a stock 1 M solution previously prepared for the physiological pH (7.4) through the Henderson-
Hasselbalch equation: 
 
 𝑝𝐻 = 𝑝𝐾𝑎 + log10 (
[𝑠𝑎𝑙𝑡]
[𝑎𝑐𝑖𝑑]
) Equation 3.4 
 
Solutions of bovine and human serum albumins were prepared for a concentration of 1.0 mg/mL, 
by weighting 10 mg of each protein and adding 10 mL of potassium phosphate buffer. 
Bovine and human plasma fibrinogen solutions were prepared for a concentration of 0.5 mg/mL, 
since these proteins become more difficult to solubilise and prone to coagulate at higher concentrations, 
by weighting 5 mg of each and adding to 10 mL of potassium phosphate buffer. 
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The concentration of all studied proteins was determined by bicinchoninic acid (BCA) assays, in 
which a calibration curve of absorbance versus protein concentration was obtained from dilutions of a 
BSA standard at 1.0 mg/mL in Milli-Q water (1.0 to 0 mg/mL in intervals of 0.2 mg/mL). A BCA and 
copper (II) sulphate mixture in a 49:1 molar ratio (known as the “working reagent”, which has a green 
colour) was added in aliquots of 475 µL to 25 µL of the BSA standard dilutions and triplicates of each 
sample in microcentrifuge tubes. All tubes were immediately placed in a heat block to incubate at 37 
ºC for 30 minutes. In the presence of peptide bonds, Cu2+ is reduced to Cu+, which forms a purple 
coloured complex with BCA, with a maximum absorbance band at 562 nm with a colour intensity 
proportional to the concentration of protein present.74 
 
3.5 Gold nanoparticle-protein conjugation 
AuNP-protein conjugates were prepared by adding to the AuNP-MUA colloidal suspensions the 
required amount of a protein for the intended protein:AuNP molar ratios, as per the following equation: 
 
 𝑉𝑝 =
𝑐𝑛𝑉𝑛𝑥
𝑐𝑝
 Equation 3.5 
 
Vp and cp represent the protein volume and concentration, respectively; Vn and cn the AuNP-MUA 
colloidal suspension volume and concentration, respectively; and x the protein:AuNP molar ratio. Once 
the protein was added, samples were shaken at 300 RPM during 15 minutes in order to uniformize the 
protein distribution, followed by an incubation at 4 ºC period. For both serum albumins, incubation was 
overnight, thus ensuring the adsorption process reached the thermodynamic equilibrium. However, for 
both fibrinogens, this period was reduced to a minimum of 2 hours, since conjugates with these proteins 
were more unstable and the AuNP were observed to begin aggregating after approximately 6 hours after 
adding the fibrinogen. 
The protein:AuNP molar ratios necessary for each different assay performed in the present work 
were varied and are indicated in the corresponding sections pertaining to the results and discussion. 
For the colloidal stability assays or studies involving the protein corona, conjugates samples were 
centrifuged at 9520 g for 10 minutes, which removes the loosely bound outer protein layers collectively 
known as the soft corona.59,61 Additionally, in the agarose gel electrophoretic assays, centrifugation was 
employed to concentrate the samples prior to loading into the gels, in order to have visible bands. Note 
that centrifugation tends to induce the aggregation of AuNP-fibrinogen conjugates, since these proteins 
coagulate from steric proximity in the pellet. 
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3.6 Molecular visualisation 
The PDB files 3V03 (BSA), 1AO6 (HSA), 1DEQ (BPF) and 3GHG (HPF) were utilised for the 
calculation of electrostatic surface potential and solvent accessibility using various software, rendering 
three-dimensional simulated protein surface projections onto which regions of different surface charges 
or accessibility to specific solvent molecules, respectively, were mapped in different colour gradients, 
thus providing invaluable insight on the structural behaviour of these proteins when interacting with the 
negatively charged AuNP. 
In order to calculate the electrostatic surface potential, the PDB files were first converted to PQR 
files, in which the temperature and occupancy columns are replaced with information regarding partial 
charge (Q) and electrostatic radius (R) for each atom; through the PDB2PQR (version 2.1.1) web server 
(http://nbcr-222.ucsd.edu/pdb2pqr_2.1.1/), using the PARSE force field and the PROPKA (version 3.1) 
web server (hosted at the PDB2PQR web site) to predict residue pKa and whole protein pI based on the 
three-dimensional structure and assign protonation states at any given medium pH. Amongst the output 
PQR files generated, an APBS input file was opened with the PyMOL software (version 2.3.2) through 
its built-in APBS plug-in, which applies the Poisson-Boltzmann equation to calculate the electrostatic 
interactions in the provided molecule and colours regions of its three-dimensional simulated surface 
projection in accordance to the charge distribution (red is more negative; blue is more positive).75 
For the solvent accessibility visualisation, the PDB files were opened with the Swiss PDB Viewer 
software (version 4.1.0), which evaluates the accessibility of each residue to a specific solvent molecule 
and colours these differentially (red is more accessible; blue is less accessible). 
 
3.7 UV-Vis spectroscopy 
All UV-Vis measurements were acquired with a Varian Cary 50 Bio UV-Vis spectrophotometer 
for a 750-350 nm wavelength range at 600 nm/min and at room temperature (25 ºC), with samples 
prepared in triplicates and placed in a Hellma quartz cuvette of 10 mm path length. 
For studies of colloidal stability with varying ionic strength, all samples were prepared with 
different concentrations of NaCl (0 to 100 mM in intervals of 10 mM, then 100 to 500 mM in intervals 
of 100 mM) to a final volume of 500 µL and incubated for 30 minutes prior to measurement, which was 
the time necessary for the aggregation effect to stabilise, as determined by David Peitinho, MSc22. 
The colloidal stability assays with pH variation were performed in a pH range of 2.0 to 8.0 in 
intervals of 0.5, with pH being adjusted with solutions of HCl 0.1 M and NaOH 0.1 M and measured 
with a Crison pH meter Basic 20+. 
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3.8 Circular dichroism spectroscopy 
CD studies were conducted on samples containing a protein concentration of 0.05 mg/mL, using 
a Hellma quartz cuvette of 1 mm path length, which was cleaned between measurements with a mixture 
of 30% HCl and 70% ethanol and thoroughly rinsed with ethanol before being blown dry with nitrogen. 
Before beginning data acquisition, a no cell baseline was performed, followed by a blank baseline only 
with potassium phosphate buffer 5 mM, pH = 7.4. Triplicate CD spectra were acquired from a Chirascan 
qCD spectrometer for a 260-195 nm wavelength range at 20 nm/min and at room temperature (25 ºC). 
Data was analysed using the BeStSel (Beta Structure Selection) web server. 
 
3.9 Dynamic light scattering 
DLS samples were prepared to a AuNP concentration of 2 nM and placed in Sarstedt PMMS 
cuvettes of four openings. Data was acquired from a HORIBA SZ-100 nanopartica analyser, equipped 
with a 532 nm green laser, in triplicate measurements of 30 seconds each and with the detection angle 
set to 90º. The instrument software automatically handled hydrodynamic diameter calculations through 
the Stokes-Einstein equation, with results expressed based on scattered light intensity.51 
 
3.10 Gel electrophoresis 
All electrophoretic assays were performed with a Bio-Rad PowerPac Basic Power Supply, which 
automatically modulates the current intensity in order to maintain constant the voltage. 
 
3.10.1 SDS-PAGE 
A “stacking gel” (4% acrylamide) and a “resolving gel” (12% acrylamide) were hand casted as 
per the following table: 
 
Table 3.1. Table of reagents for the preparation of a stacking gel (4%) and a resolving gel (12%), according to the 
protocol for SDS-PAGE by Bio-Rad Laboratories, Inc. 
Reagents Stacking gel (4%) Resolving gel (12%) 
30% Acrylamide/Bis 1.98 mL 6.00 mL 
0.5 M Tris-HCl, pH = 6.8 3.78 mL - 
1.5 M Tris-HCl, pH = 8.8 - 3.75 mL 
10% SDS 150 µL 150 µL 
Milli-Q H2O 9.00 mL 5.03 mL 
TEMED 15 µL 7.5 µL 
10% APS 75 µL 75 µL 
Total volume 15 mL 15 mL 
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The two final reagents listed, tetramethylethylenediamine (TEMED) and ammonium persulfate 
(APS), trigger the polymerisation reaction, hence these were added last and immediately before casting 
the gels, with the resolving gel being placed first in the glass cast and left to polymerise for 1 hour, after 
which the stacking gel was added on top of the former and left to polymerise for another hour, with the 
resulting interface between both gels being important for an increased band resolution in the resolving 
gel, as the samples concentrate here, after quickly descending the high-porosity stacking gel. 
The glass cast with both gels encased was then inserted into a Bio-Rad Mini-PROTEAN Tetra 
Electrode Assembly, which was subsequently placed inside a Bio-Rad Mini-PROTEAN Tetra Vertical 
Electrophoresis Cell. The former was entirely filled with “running buffer” (0.192 M glycine, 0.025 M 
Tris and 0.1% SDS), whilst the latter was only filled to the marked level. 
All protein samples and marker solution (Bio-Rad Unstained Low Range SDS-PAGE Standard) 
were submitted to a denaturing treatment through both a chemical and a physical process, in which to 
20 µL of the former and 3 µL of the latter were added 10 and 5 µL, respectively, of a “sample buffer” 
(1% (w/v) bromophenol blue, 10% (w/v) SDS, 10% (v/v) glycerol 87%, 0.5 M Tris-HCl, pH = 6.8; and 
715 mM β-mercaptoethanol, which is a denaturing agent and should be added immediately prior to use) 
and an additional 2 µL of Milli-Q water to the latter, before placing samples and marker in a water bath 
at 100 ºC for 10 minutes and subsequently centrifuging these at 13000 g for 2 minutes. 
15 µL of each protein sample and 3µL of marker solution were loaded into the stacking gel and 
the power supply was set to apply 150 V for 1 hour, until the sample buffer blue line reached near the 
opposite extremity of the resolving gel, after which both gels were removed from the glass cast whilst 
submerged in Milli-Q water and placed in a plastic container filled with a “staining solution” (10% (v/v) 
glacial acetic acid, 2% (w/v) Coomassie Brilliant Blue R-250 Dye and 35% methanol) overnight and 
then rinsed in successive cycles with a “distaining solution” (50% (v/v) absolute ethanol and 10% (v/v) 
glacial acetic acid) until the bands could be discerned from the background. 
 
3.10.2 Agarose gel electrophoresis 
All AGE assays were conducted on 0.5% (w/v) agarose gels, which were prepared by weighting 
0.225 g of agarose and solubilising it in 45 mL of a 1:400 dilution of a stock TAE buffer (24.2% (w/v) 
Tris, 5.71% (v/v) glacial acetic acid and 10% (v/v) 0.5 M EDTA) under constant heating and magnetic 
stirring, after which it was cooled down at room temperature (25 ºC) for approximately 15 minutes and 
placed in the cast. Note that it is important to allow the heated agarose solution to cool down for some 
time before the gelation reaction begins, as pouring it too hot on the cast can damage it. Once solid, the 
cast was inserted into a Bio-Rad Mini-Sub Cell GT, which was filled with the 1:400 dilution of stock 
TAE buffer to the marked level. Note that the high dilution factor of the TAE buffer was to minimise 
the risk of ionic-strength-induced aggregation of AuNP in the samples; however, this also increases the 
electrical resistance and, consequently, temperature, causing anomalies in the gel, which was subsided 
by having the agarose gel and TAE buffer cooled down to 4 ºC prior to use. 
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AuNP-protein conjugates samples for AGE were prepared with an initial AuNP concentration 
of 1-2 nM for the smaller AuNP and 0.1 nM for the larger ones, to which the amount of protein required 
for the intended molar ratios was added, followed by a conjugation procedure as described above, after 
which all samples were centrifuged at 9520 g for 10 minutes, the supernatant discarded and the pellets 
resuspended in 13.5 µL potassium phosphate buffer 5 mM, pH = 7.4 and 1.5 µL glycerol immediately 
before loading into the agarose gel. Alternatively, the pellets can be resuspended in 15 µL of potassium 
phosphate buffer 5 mM, pH = 7.4; as AuNP are dense enough to deposit in the wells without glycerol. 
15 µL of each sample were loaded into the agarose gel and the power supply was set to apply 
150 V (E = 1042 V/m) for 20-30 minutes, depending on the assay performed, after which the gel was 
removed from the cast to be photographed. 
 
3.10.3 Gel image analysis 
Digital electrophoresis gel images were processed in the free and open source software, eReuss 
(version 0.01) (https://github.com/lkrippahl/eReuss), created and developed by Prof. Ludwig Krippahl, 
which requires Python 2.7 and the libraries Scipy, Numpy, Scikit-image and Matplotlib, all included in 
the Anaconda package distributed by Continuum Analytics (https://www.anaconda.com/distribution/). 
Upon initiating the eReuss server, a loop-back address was opened on a web browser by typing 
127.0.0.1:8081 on the address bar, which connects to the eReuss server running on the background and 
provides a graphical user interface to the software. 
The electrophoresis gel image to be processed was uploaded in the first page and then prepared 
for automated analysis in the following pages (note that, as of version 0.01, eReuss only recognises gel 
images oriented vertically, with band migration from top to bottom; and does not have a rotation option, 
hence all images were rotated, if necessary, externally and prior to upload). 
In “Image preprocessing”, the band colour was specified on the respective drop-down list (red 
for AGE AuNP conjugates samples and blue for Coomassie-stained SDS-PAGE), which allows eReuss 
to ignore that RGB channel in the background, thus improving contrast between the gel and the bands. 
Additionally, the colours were inverted so that the bands appeared bright on a dark background, as the 
software measures band colour intensity by pixel brightness. 
In “Clipping”, all gel dimensions (comb length, in cm, measured between the beginnings of the 
first and last teeth; number of comb teeth and number of used wells only) were inserted in the respective 
boxes, which eReuss uses to calculate band migration distances through a pixel to centimetre conversion 
and to establish the number of lanes to be processed. Moreover, a region of interest (ROI) for the image 
was defined, as shown in figure 3.2. 
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Figure 3.2. Delimitation of the ROI in an agarose gel containing AuNP conjugates samples with the cyan rectangle 
outline and a yellow horizontal line placed above the wells, which marks the starting point of migration. 
 
In “Lane identification”, eReuss automatically assigned the band colour intensity profiles to the 
established vertical lanes for each band (note that a manual tuning of this alignment is possible in this 
page, if necessary), generating the graph in figure 3. 
 
 
Figure 3.3. In the lane identification graph, the band colour intensity profiles (in blue) are aligned with the lanes 
the software recognised (in yellow, where the gaps represent the spaces between each lane). 
 
In “Profiling”, eReuss measures the colour intensity profile in each lane and identifies the peaks 
by iteratively fitting a Gaussian distribution to the maximum value in each curve and subtracting that 
distribution repeatedly until either the set number of Gaussians was reached or the maximum value falls 
below the set minimum height, which is the percentage of the image brightness range. These parameters, 
along with smoothing the lane profiles and the polynomial degree for the baseline, were left at default 
values, although manual tuning was possible, if necessary. 
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Figure 3.4. Rendering of a band migration profile graph, where the green vertical line marks the start of migration 
(where the wells are located) and the black horizontal plots represent the migration profile for each lane, with the 
overlaying red lines fitting Gaussian curves at the colour intensity peak position (also marked in red) of each band. 
 
In “Final report”, results were summarised and a ZIP file exported, containing the PNG files of 
the pre-processed and clipped gel image and the band migration profile graph, an XML file of detailed 
data on band migration profiles and a CSV file in which a table of peak positions, heights and areas, in 
centimetres, can be found. 
With the migration distance of each band and knowing the electric potential difference and run 
time, it was possible to calculate the electrophoretic mobility (µ; m2V-1s-1) of each sample. For the AGE 
assays, since the band mobility decreased as the protein:AuNP molar ratio increased, the electrophoretic 
mobility difference between the unconjugated and each of the conjugated samples was plotted against 
the protein concentration (using the OriginPro 2018 software), resulting in a curve which could be fitted 
to a Hill-Langmuir equation: 
 
 
𝛥µ = 𝛥µ𝑚𝑎𝑥
𝑐𝑛
(
1
𝐾𝑎
)
𝑛
+ 𝑐𝑛
 
Equation 3.6 
 
Δµ is the electrophoretic mobility difference, Δµmax the maximum value it tends to, c the initial 
protein concentration, n the Hill coefficient and Ka the binding constant. The Hill coefficient designates 
the binding cooperativity, which is negative if n < 1, positive if n > 1 or uncooperative if n = 1, the latter 
being formally equivalent to the Langmuir adsorption model. The binding constant is the inverse of the 
dissociation constant, Kd, or the protein concentration at which half of all AuNP have protein adsorbed 
to its surface. 
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4 Results and discussion 
4.1 Gold nanoparticles – from synthesis to conjugation 
In the inverse Turkevich method, quality assessment during AuNP synthesis was performed by 
naked eye observation of successive colour changes in the boiling sodium citrate solution upon adding 
the chloroauric acid, which starts yellow from the latter and immediately becomes colourless as a 
consequence of being reduced to Au0 by the sodium citrate, initiating nucleation and from which AuNP 
growth ensues, indicated by a quick change to a dark colour, gradually stabilising to dark red. 
 
 
Figure 4.1. 13 nm AuNP-citrate colloidal suspension diluted to 10 nM from the as-synthesised concentration of 
11 nM. 
 
Once the reaction was stopped and the AuNP-citrate colloidal suspension was cooled down and 
subsequently filtered in order to remove larger formations and ensure a low polydispersity, triplicate 
samples were taken for UV-Vis spectroscopy characterisation of diameter and concentration.  
 
 
Figure 4.2. UV-Vis absorbance spectra of 1:2 dilutions of 13 nm and 42 nm AuNP-citrate. For AuNP with ca. 13 
nm in diameter (left panel), the absorbance values at 450 nm and at the LSPR peak, 520 nm are used to calculate 
the diameter of AuNP and concentration of the AuNP colloidal suspension. For AuNP with ca. 42 nm in diameter 
(right panel), this calculation requires the absorbance value at 450 nm and the value of the wavelength at the LSPR 
peak, 528 nm. 
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The method used for the synthesis of smaller AuNP yielded diameters of 10-15 nm in different 
synthesis, with low polydispersity for each lot; and concentrations of 7-21 nM, inversely proportional 
to the diameter, since larger AuNP take up more Au0 atoms, thus reducing the overall number of AuNP. 
Likewise, the method used for the synthesis of larger AuNP yielded diameters of 40-45 nm in different 
synthesis, with low polydispersity for each lot; and concentrations of 0.1-0.5 nM, inversely proportional 
to the diameter. The discrepancy between the concentrations obtained for smaller and larger AuNP can 
also be explained by the aforementioned fact. 
 
Table 4.1. Diameter and concentration calculated for AuNP synthesised in the present work. 
Diameter (nm) Concentration (nM) 
12.10 13.76 
13.02 11.18 
14.78 6.80 
15.56 4.60 
41.66 0.22 
 
Post-synthesis quality assessment could be observed from the single peak in the UV-Vis spectra, 
whose narrow width indicates low polydispersity and the low absorbance at 750-600 nm the absence of 
extensive AuNP aggregation. 
The LSPR peak suffers a red-shift with the increase of particle size, hence the 8 nm difference 
between the UV-Vis spectra for 13 and 42 nm AuNP. Because of this reason, a red-shift also occurs as 
AuNP aggregate, which can be exploited to detect the formation of aggregates. 
A slight red-shift can indicate functionalization success with a larger capping agent molecule, 
such as MUA, or conjugation success with protein, all of which contribute to a different refractive index 
at the surface of the AuNP. 
In order to determine the amount of MUA necessary to cover the entire surface of AuNP, an AGE 
assay was performed for each AuNP size with increasing MUA:AuNP molar ratios. Due to possible 
interactions between citrate and agarose, which would leave the AuNP uncovered to aggregate, an 
insufficient amount of MUA can be observed by the formation of aggregates in the wells and smearing 
along the gel (figures 4.3 and 4.4).  
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Figure 4.3. Agarose gel (0.5%) electrophoresis of 13 nm AuNP-citrate with increasing MUA:AuNP ratios. 
 
 
Figure 4.4. Agarose gel (0.5%) electrophoresis of 42 nm AuNP-citrate with increasing MUA:AuNP ratios. 
 
From these results, the MUA:AuNP molar ratios of 5000 and 15000 for AuNP of 13 and 42 nm, 
respectively, were selected as the ideal amounts of MUA at which no aggregates were detected in the 
wells and band smearing was minimum. 
After the functionalization procedure, any excess MUA was removed through centrifugation. In 
order to validate functionalization success, with absent signs of aggregation, triplicate samples were 
taken for UV-Vis spectra comparison with the respective AuNP-citrate samples (figure 4.5). 
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Figure 4.5. Comparison between the normalized UV-Vis absorbance spectra of unfunctionalized AuNP, in black; 
and functionalized with MUA, in red; for AuNP of 13 nm (left) and 42 nm (right). 
 
The slight red-shifts confirm a successful functionalization, with 6 nm for the 13 nm AuNP and 
2 nm for the 42 nm AuNP. Note that the smaller red-shift for the larger AuNP is expected, since the 
difference in refractive index at the AuNP surface is more subtle, with no observable aggregation, as 
indicated by the low absorbance at 750-600 nm. 
Conjugation with protein was also evaluated through UV-Vis spectroscopy prior to assays using 
AuNP-protein conjugates samples, based on the same principle. For example, a red-shift of 7 nm was 
measured for 13 nm AuNP-MUA upon conjugation with bovine serum albumin (BSA) (figure 4.6). 
 
 
Figure 4.6. Comparison between the normalized UV-Vis absorbance spectra of unconjugated 13 nm AuNP-MUA, 
in red; and conjugated with BSA, in blue. 
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4.2 Protein quantitative and qualitative characterisation 
A bicinchoninic acid (BCA) assay was performed for all protein solutions prepared, in order to 
quantitate protein concentration, whilst SDS-PAGE allowed for the evaluation of both stock protein 
quality and molecular weights, given the sequential and structural differences between the studies 
proteins (BSA, HSA, BPF and HPF). 
 
4.2.1 Bicinchoninic acid assay 
A calibration curve was obtained from a BSA standard and used for all studied proteins. The 
studied proteins present a different number of residues which are known to directly influence colour 
formation, namely Cys, Tyr and Trp (table 2).74,76,77 This is especially evident for plasma fibrinogen, 
yet this discrepancy is minimised by different residue accessibilities and the fact that the universal 
peptide backbone also contributes to colour formation.76,77 
 
Table 4.2. Number of cysteine, tyrosine and tryptophan residues in BSA, HSA, BPF and HPF. 
No. of residues BSA HSA BPF HPF 
Cysteine 35 35 54 58 
Tyrosine 20 18 92 96 
Tryptophan 2 1 66 66 
Total 57 54 212 220 
 
This is important to consider, since some proteins reduce different amounts of Cu2+ than BSA, 
therefore resulting in a different absorbance at 562 nm of the BCA-Cu+ complexes formed for the same 
protein concentration.76 
However, good correlations were found between the theoretical protein concentration (mg/mL) 
calculated from the amount of protein weighted (mg; purity was considered) and volume of buffer (mL); 
and the protein concentration determined by the BCA assay, for serum albumins and fibrinogens alike 
(table 4.3). 
 
Table 4.3. Correlation between the theoretical concentration of each protein solution and respective concentration 
determined by the BCA assay 
Protein 
Theoretical concentration 
(mg/mL) 
Concentration as per the 
BCA assay (mg/mL) 
Correlation 
(%) 
BSA 0.5 0.492 98.4 
HSA 0.5 0.501 99.8 
BPF 0.5 0.447 89.4 
HPF 0.5 0.493 98.6 
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Figure 4.7. BSA standard calibration curve for the BCA assay and respective equation, fitted with an R2 = 0.994. 
 
4.2.2 SDS-PAGE 
In order to evaluate stock protein quality for each studied protein (BSA, HSA, BPF and HPF) 
and compare the monomeric molecular weights between respective bovine and human counterparts, an 
SDS-PAGE was performed. 
 
 
Figure 4.8. SDS-PAGE with bovine and human counterparts of serum albumin (BSA and HSA, respectively) and 
of plasma fibrinogen (BPF and HPF, respectively), using a low molecular weight standard (LMW std). 
 
This SDS-PAGE image was processed through the eReuss software, set to detect six peaks of 
band colour intensity – assigning a Gaussian curve to each one – per the six standard bands, which were 
subsequently used to calculate a calibration curve through which the monomeric molecular weights for 
each studied protein were estimated in function of electrophoretic mobility of respective band or bands 
(the one with the highest colour intensity for both serum albumins and the three highest for fibrinogens). 
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Figure 4.9. eReuss SDS-PAGE band migration profile (left), through which a molecular weight calibration curve 
in dependence of electrophoretic mobility (right) and respective equation (R2 = 0.979) were obtained from the low 
molecular weight standard (LMW std) profile. 
 
Table 4.4. Comparison between the monomeric molecular weights obtained from the eReuss SDS-PAGE analysis 
and those found in literature. 
Protein Chains Literature MW (kDa) Estimated MW (kDa) 
BSA (Monomer) 6912,13 71.9 
HSA (Monomer) 6914 68.8 
BPF 
Αα 63.518 
Total 
340-34218 
69.9 
Total 
351.4 
Ββ 5618 59.9 
γ 4718 45.9 
HPF 
Αα 64-7019,20 
Total 
342-38319,20 
76 
Total 
364.2 
Ββ 57-5819,20 59.3 
γ 48-4919,20 46.8 
 
From a naked eye analysis of the gel image, both BSA and HSA appeared quite identical and 
in agreement with the molecular weights found in literature12–14; although, for the fibrinogens, only BPF 
distinctly exhibited the expected three bands respective to its Αα, Ββ and γ chains (in descending order 
of molecular weight)18–20, whereas HPF corresponded only in the γ chains, whilst Αα and Ββ were more 
difficult to differentiate and blended into a smear of an apparent higher molecular weight; however, this 
was resolved after the image was analysed with eReuss and the estimated monomeric molecular weights 
matched the reference ones, albeit with some overestimation for BSA and both fibrinogens. 
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4.2.3 Molecular visualisation 
Sequence and structural comparison between the bovine and human counterparts of the studied 
proteins had already been done by David Peitinho, MSc22, using the same PDB files – 3V03, 1AO6, 
1DEQ and 3GHG for BSA, HSA, BPF and HPF, respectively – and performing both a global and local 
sequence alignment through the Needleman-Wunsch and blastp algorithms, respectively; utilising the 
BLAST 2 Sequences software.78 Additionally, a rigid and flexible structural alignment were conducted 
through the jFatCat algorithm, tool available at a RCSB PDB web server.79 
 
Table 4.5. Sequence alignment between the bovine and human counterparts of serum albumin and fibrinogen. 
Proteins 
Bovine and human sequence alignment 
Global Local 
Identity Similarity Gaps Identity Similarity Gaps 
Serum albumins 76% 88% 0% 76% 88% 0% 
Fibrinogens 
Αα 44% 51% 31% 58% 68% 10% 
Ββ 77% 85% 4% 82% 91% 0% 
γ 80% 88% 2% 81% 90% 1% 
 
Table 4.6. Structural alignment between the bovine and human counterparts of serum albumin and fibrinogen. 
Proteins 
Bovine and human structural alignment 
Rigid Flexible 
Similarity Gaps Similarity Gaps 
Serum albumins 88% 0% 88% 0% 
Fibrinogens 
Αα 82% 3% 82% 0% 
Ββ 91% 6% 93% 0% 
γ 91% 2% 91% 0% 
 
Overall, both bovine and human counterparts of each studied protein exhibited a high sequence 
and structural homology (> 60%), with the exception being the Αα chains of fibrinogens, which scored 
poorly in the global sequence alignment, although, in the local alignment, these scored slightly higher 
due to the detection of conserved domains. This could be explained by the high incompletion of these 
chains in the PDB files, as verified by comparing the number of residues with the respective and more 
complete UniProt files (table 4.7).  
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Table 4.7. Comparison between the number of residues of BSA, HSA, BPF and HPF found in the respective PDB 
and UniProt files. 
Files BSA HSA 
BPF HPF 
Αα Ββ γ Αα Ββ γ 
PDB 583 585 390 408 411 562 461 411 
UniProt 617 619 615 468 444 866 491 453 
 
In order to further evaluate the structural similarities between the corresponding studied protein 
counterparts, the electrostatic surface potentials were mapped onto computer generated representations 
of each protein at different pH, defined when converting the PDB files to PQR files using the PDB2PQR 
web server. This also served to understand how pH alters the electronegativity at the surface of these 
proteins and how the adsorption to the negatively charged AuNP is affected. Due to the high sequential 
incompletion in the PDB file for BPF, the software could not process it for molecular visualisation. 
The surface protonation patterns of both serum albumins (figures 4.10 and 4.11) appeared quite 
similar at the different pH simulated, revealing a prominent negative region pertaining to domain I – 
particularly above the pI of these proteins (5.41 for BSA; 5.47 for HSA) – and a positive site focused 
on a central, interior region, which could be a potential binding point to the AuNP, therefore 
conformational alterations upon adsorption are expected. Moreover, this positive site appears to expand 
to nearly cover the entire protein surface once the pH drops below the pIs. This could induce the 
aggregation of AuNP, since more than one negatively charged AuNP can bind to a protein surface with 
a predominantly positive charge. 
For HPF (figure 4.12), given the size and shape of the fibrinogen molecule, the location of 
potential binding points to the AuNP suggest it can either adsorb to more than one AuNP, or bend to 
adsorb to the same nanoparticle at different points. 
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Figure 4.10. Electrostatic potential mapped onto a surface projection of BSA (PDB 3V03) at pH 2, 4, 6 and 8 in 
a colour gradient (red is negative, white neutral and blue positive) ranging from -5.0 to 5.0 kb T ec-1. 
 
 
Figure 4.11. Electrostatic potential mapped onto a surface projection of HSA (PDB 1AO6) at pH 2, 4, 6 and 8 in 
a colour gradient (red is negative, white neutral and blue positive) ranging from -5.0 to 5.0 kb T ec-1. 
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Figure 4.12. Electrostatic potential mapped onto a surface projection of HPF (PDB 3GHG) at pH 2, 4, 6 and 8 in 
a colour gradient (red is negative, white neutral and blue positive) ranging from -5.0 to 5.0 kb T ec-1. 
 
Furthermore, the studied proteins were structurally compared between respective counterparts 
and studied for the solvent accessibility of each amino acid. This parameter is typically reported as the 
percentage of the accessible surface of each residue relative to that for the model pentapeptide GGXGG 
in its extended conformation. An entirely exposed residue would score a solvent accessibility of 100%, 
whereas those completely buried possess a solvent accessibility of 0%.80 Thus, solvent accessibility was 
mapped onto every single amino acid of the studied proteins in a simulated projection, as well as onto 
all cystine residues only in another. Cysteines are important because of their thiol group, which – given 
the strength of the Au-S covalent bond – contribute to the stabilisation of the AuNP conjugates, despite 
not affecting the initial binding or the overall kinetics of the adsorption mechanism.81,82 Paired with the 
electrostatic surface potential data, this also allowed to predict potential conformational alterations to 
the structure of these proteins upon adsorbing to the surface of AuNP, considering the accessibility of 
the amino acids which constitute binding points. 
From the electrostatic surface potential data, the central, internal region of both serum albumins 
(figures 4.13 and 4.14) and the extremities and central region of HPF (figure 4.15) constitute the most 
probable AuNP contact points. These regions, from the solvent accessibility data, also reveal very low 
accessibility. This is also the case for cysteine residues, further suggesting conformational alterations 
are expected for these proteins upon AuNP adsorption. 
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Figure 4.13. Solvent accessibility mapped onto each amino acid (left) and onto all cysteine residues only (right) 
of BSA (PDB 3V03) relative to a reference 100% accessibility computed for the model pentapeptide GGXGG, 
represented in the inset colour gradient. 
 
 
Figure 4.14. Solvent accessibility mapped onto each amino acid (left) and onto all cysteine residues only (right) 
of HSA (PDB 1AO6) relative to a reference 100% accessibility computed for the model pentapeptide GGXGG, 
represented in the inset colour gradient. 
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Figure 4.15. Solvent accessibility mapped onto each amino acid (left) and onto all cysteine residues only (right) 
of HPF (PDB 3GHG) relative to a reference 100% accessibility computed for the model pentapeptide GGXGG, 
represented in the inset colour gradient. 
 
4.3 Colloidal stability assays 
UV-Vis spectroscopy was employed in the comparative study of the colloidal stability of 
unfunctionalized 13 nm AuNP-citrate, MUA-functionalized AuNP and these AuNP-MUA conjugated 
with each of the studied proteins. These studies allowed to establish aggregation profiles with varying 
ionic strength and pH in order to further understand the colloidal behaviour of these nanoparticles and 
their conjugates. Moreover, complementarily to the previous assessment of protein electrostatic surface 
potential and solvent accessibility, these studies also allowed to characterise the surface protonation 
patterns for BSA, HSA, BPF and HPF, thus inferring how these proteins adsorb to the AuNP surface. 
Conjugates were prepared in specific protein:AuNP molar ratios determined by AGE assays to 
ensure a complete coverage of the surface of AuNP with minimal excess (70:1 for both serum albumins; 
8:1 for both fibrinogens). Further information on these AGE assays is detailed in the following section 
regarding AGE assays results. 
Considering the LSPR absorbance peak of aggregated AuNP undergoes a red-shift in relation to 
the non-aggregated LSPR to approximately 600 nm, that wavelength was assumed as the “aggregation 
peak” for the aggregation quantification of AuNP and AuNP conjugates, in which the absorbance at 
600 nm was divided by the absorbance at the LSPR peak of blank samples. 
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Figure 4.16. Unaggregated AuNP conjugate sample (left) with a highly aggregated one (right). 
 
The aggregation profiles obtained from the A600 nm/ALSPR quotient produced sigmoidal curves 
to which the logistical dose response function could be fitted in order to find the inflection point, which 
represents the critical coagulation concentration (CCC), or the minimum concentration of counterions 
necessary to aggregate the AuNP49,50: 
 
 
𝐴600 𝑛𝑚
𝐴𝐿𝑆𝑃𝑅
=
𝐴1 − 𝐴2
1 + (
𝑥
𝑥0
)
𝑝 + 𝐴2 Equation 4.1 
 
A1 and A2 are the initial and final values, respectively, of the sigmoidal curve, x0 its centre – the 
salt concentration or the pH at the inflection point – and p a power computed for the best fitting possible 
of the function to the curve. 
 
4.3.1 Ionic strength 
A monovalent salt, NaCl was used to increase the ionic strength in the medium of AuNP and 
AuNP conjugates with each of the different studied proteins, whilst maintaining a constant pH. 
The calculation of the CCC for unfunctionalized AuNP-citrate and functionalized AuNP-MUA 
had already been done by David Peitinho, MSc22, namely 28 nM of NaCl for the former and 277 nM 
for the latter. 
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Figure 4.17. Comparison between the UV-Vis absorbance spectra of a blank, unaggregated AuNP-BSA sample 
(no NaCl) and one highly aggregated with 500 mM of NaCl, incubated for 30 minutes prior to measurement. 
 
 
Figure 4.18. Colloidal stability profiles of 13 nm AuNP-MUA conjugated with BSA and HSA with increasing 
ionic strength through increment of NaCl concentration. 
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Figure 4.19. Colloidal stability profiles of 13 nm AuNP-MUA conjugated with BPF and HPF with increasing 
ionic strength through increment of NaCl concentration. 
 
AuNP conjugates of either serum albumin counterpart exhibited identical aggregation profiles 
with the increasing ionic strength, yet it was not possible to estimate the CCC due to the inflection point 
not being reached with the NaCl concentration range used. 
In the case of the fibrinogens, however, the aggregation profiles suggested a great difference in 
the colloidal stability of both AuNP conjugates relative to the unconjugated AuNP. This is corroborated 
by the calculated CCC of 165 and 172 nM of NaCl for the bovine and human counterpart, respectively. 
The values are similar and below the CCC for the unconjugated AuNP (277 nM), indicating that AuNP 
conjugates with BPF or HPF are more unstable than the unconjugated AuNP. 
 
4.3.2 pH effect 
AuNP and AuNP conjugates samples were adjusted to pH in a range from 2.0 to 8.0 in intervals 
of 0.5 with HCl or NaOH, as negatively charged AuNP are more unstable at acidic pH than basic. Care 
was taken so that both HCl and NaOH were never added to the same sample, as the resulting NaCl salt 
would overestimate the results through ionic-strength-induced aggregation. 
The CCC for unfunctionalized AuNP-citrate and functionalized AuNP-MUA had already been 
estimated by David Peitinho, MSc,22 as 2.7 and 3.9, respectively, which were similar to the respective 
reference pKa of citrate and MUA, 3.1 and 4.5.73,83 
Although the colloidal stability profile of AuNP-BSA conjugates displayed an apparent slightly 
poorer efficiency in shielding the AuNP from protonation than HSA, the calculated CCC for both 
counterparts were similar, at 5.3 and 5.2, respectively, which were good approximations to the pI of 
these proteins (5.41 for BSA; 5.47 for HSA) (figure 4.20). 
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Conversely, the AuNP-fibrinogen conjugates presented an identical estimated CCC of 5.6, 
albeit more contrasting with the pI of these proteins (6.48 for BPF; 6.12 for HPF) (figure 4.21). This 
difference can be explained by the size, shape and location of the several potential AuNP contact points 
throughout the surface of fibrinogens, as observed in the electrostatic surface potential visualisation, 
resulting in conformational alterations in which the protein is still bound to the surface of AuNP, up to 
a certain protonation level, in such a way it protects the latter from aggregation. 
Moreover, all protein conjugates exhibited an apparent reduced aggregation or disaggregation 
profile at the lowest pH measured (approximately between 2.0 and 3.0), even lower than the point of 
maximum aggregation for each conjugate. One possible explanation is that, considering the proteins 
possess a mostly positive surface charge at these pH – as shown in the electrostatic surface potential – 
and since the AuNP are entirely covered by protein, the electrostatic repulsions between the positively 
charged protein coatings of the AuNP impede these from aggregating. 
 
 
Figure 4.20. Colloidal stability profiles of 13 nm AuNP-MUA conjugated with BSA and HSA with different pH.  
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Figure 4.21. Colloidal stability profiles of 13 nm AuNP-MUA conjugated with BPF and HPF with different pH. 
 
4.4 Circular dichroism analysis of the secondary structure of conjugated proteins 
Conformational alterations on the secondary structure of the studied proteins upon adsorption to 
the surface of AuNP and consequent integration at the different protein coronas were assessed through 
CD spectroscopy at a 260-195 nm wavelength range, in which unaggregated AuNP produce no signal.84 
This was performed by comparing the CD spectra of the free proteins with those of conjugates samples 
in increasing protein:AuNP ratios. The values for these ratios were selected to include the conjugation 
curve observed in AGE assays, corresponding to the first protein monolayer (hard corona) formation. 
Further information on these AGE assays is detailed in the following section. 
In order to ensure good CD data quality, the absorbance and high-tension voltage being applied 
to the photomultiplier were monitored during measurements, which should never surpass 1 and 700 V, 
respectively, otherwise the detector would be saturated.85 As the protein concentrations were maintained 
at an optimal 757.6 nM for both serum albumins and 147.1 nM for both fibrinogens, much higher AuNP 
concentrations were required for the intended protein:AuNP ratios, which also caused an intensification 
of the absorbance and high-tension voltage on the photomultiplier. A good compromise was found for 
the serum albumin conjugates, but not for the fibrinogen ones, as either the protein concentration would 
have to be too low to acquire data of an acceptable quality, or the required high AuNP concentrations 
would increase the absorbance and high-tension voltage on the photomultiplier above the respective 
maximum thresholds, hence CD studies could not be conducted on AuNP conjugates with fibrinogens. 
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The CD spectra of both unbound serum albumin counterparts present the aspect characteristic to 
proteins predominantly comprised of α-helices, which is in agreement with the literature. Interestingly, 
the density of this secondary structure motif slightly decreases approximately 10.4% and 8.6% for BSA 
and HSA, respectively, as these proteins adsorb to AuNP. This validates the conformational alterations 
predicted from the previous electrostatic surface potential and solvent accessibility data, which showed 
the positively charged regions at the working pH (7.4) are mainly located centrally and internally in the 
proteins, as are the residues constituting binding points to the AuNP mostly buried, hence these proteins 
were expected to change structurally in order to expose these positive regions and binding points to the 
AuNP surface. 
The calculated loss of α-helices for serum albumins in the present work corroborates the findings 
of Wang et al.86, who also demonstrated the AuNP surface composition affects differently the secondary 
structure changes suffered by BSA, although AuNP-MUA was not studied. However, some proteins do 
not undergo drastic conformational alterations upon adsorption to AuNP, as Gomes et al.87 verified with 
cytochrome c, which can be explained by the fact the binding points of this protein to the AuNP surface 
are located more externally and that it possesses two faces of a distinct electrostatic surface charge, one 
of which with a predominantly positive and easily accessible to the negatively charged AuNP, therefore 
not requiring considerable structural changes in order to expose its binding points. 
Furthermore, a minor recovery of the original secondary structure of an estimated 1.6% and 0.9% 
for BSA and HSA, respectively, was observed as the protein:AuNP ratio increases and more protein 
layers are formed. Since this technique measures the secondary structure of the outermost surface layer 
of conjugates, this could indicate that the greater the distance between these proteins and the AuNP, the 
less conformational alterations the former suffer. 
 
 
Figure 4.22. Comparison between the CD spectra in a wavelength range of 260-195 nm of free, unbound BSA 
and bound to 13 nm AuNP-MUA in increasing protein:AuNP molar ratios. 
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Figure 4.23. Comparison between the CD spectra in a wavelength range of 260-195 nm of free, unbound HSA 
and bound to 13 nm AuNP-MUA in increasing protein:AuNP molar ratios. 
 
4.5 Dynamic light scattering analysis of the protein corona hydrodynamic diameter 
Some literature7,8,59,61 claims centrifugation can effectively remove the loosely bound outer layers 
of a protein corona (collectively known as the soft corona) by disrupting the protein-protein interactions, 
which are comparatively weaker than those established at the AuNP surface. Since these AuNP-protein 
interactions can withstand the high centrifugal force, the innermost protein monolayer (hard corona) is 
preserved after centrifugation. Thus, the centrifugation of AuNP conjugates was the method employed 
to obtain samples of AuNP bearing only the innermost hard corona monolayer. 
 
 
Figure 4.24. Centrifugation can break the weaker protein-protein interactions, allowing for the removal of the soft 
corona.  
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An approach to characterise the protein corona formed on AuNP with each of the studied proteins 
was the comparative measurement of the hydrodynamic diameters, through DLS, of conjugates samples 
with both coronas intact and with the hard corona only, the latter obtained after sample centrifugation. 
First, the hydrodynamic diameters of unfunctionalized 13 nm AuNP-citrate, of the same AuNP 
functionalized with MUA and of AuNP-MUA conjugated with a monolayer of BSA were measured, as 
in theory these should increase in this order, since MUA is a longer molecule than citrate and the protein 
monolayers add to the overall size of the conjugates. 
The results were favourable to theory, as a clear and consistent hydrodynamic diameter increment 
was observed as citrate is replaced with the longer MUA and again as BSA is adsorbed to AuNP. The 
difference in hydrodynamic diameter between AuNP-citrate and AuNP-MUA of approximately 2.4 nm 
is in agreement with the same findings by Ansar et al.88, who calculated a difference of 2.0 nm. Despite 
this, it should also be noted that the polydispersity index also increases greatly, not to mention the width 
of all three peaks indicates some colloid size polydispersity, yet independent of the presence of protein, 
as evidenced by how identical the peaks appear otherwise. 
 
 
Figure 4.25. Size distribution of unfunctionalized 13 nm AuNP samples, in black; functionalized with MUA, in 
red; and bearing a hard corona of BSA, in blue. The peak modes for AuNP-citrate, AuNP-MUA and AuNP- BSA 
were 17.9, 20.3 and 25.9 nm, with z-averages of 19.4, 25.9 and 26.9 nm and polydispersity index values of 0.154, 
0.373 and 0.409, respectively. 
 
Thus, the hydrodynamic diameters were determined for AuNP of 13 and 42 nm, conjugated with 
purposely excessive amounts of BSA, HSA, BPF or HPF to ensure a full surface coverage (10000:1 for 
the serum albumins; 200:1 for fibrinogens); and with the respective hard corona samples centrifuged. 
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Figure 4.26. Samples of 42 nm AuNP-MUA 2 nM conjugated with BSA and HSA in a 10000:1 protein:AuNP 
ratio and with BPF and HPF in a 200:1 protein:AuNP ratio. 
 
Centrifugation was verified to induce AuNP aggregation with a higher probability for conjugates 
samples presenting some instability, such as the fibrinogen ones, particularly for higher protein:AuNP 
molar ratios, which were beginning to shift to a bluer hue after the conjugation procedure. However, it 
should also be considered that denser aggregates amidst the colloidal suspension precipitate, whereas 
unaggregated particles remain suspended and in the laser path, albeit the sample concentration decreases 
with the formation of precipitates. This is not be a problem, however, since DLS is a sensitive technique 
which can measure highly diluted samples.51 
Interestingly, a decrease in hydrodynamic diameter for the centrifuged samples, as theoretically 
expected, was observed in the smaller, 13 nm AuNP conjugated with either serum albumin; and in the 
larger, 42 nm AuNP with either fibrinogen counterparts (figures 4.27 to 4.31). Supplemental data with 
z-average and polydispersity index values can be found in Appendix IV, table IV.1. 
One possible explanation for the high discrepancy found between the sizes of uncentrifuged and 
centrifuged 13 nm AuNP conjugated with fibrinogen is that, given to the structural shape and tendency 
to coagulate characteristic to this protein, as well as being much larger than the AuNP, it could adsorb 
to more than one nanoparticle with higher probability due to steric proximity when compressed into a 
pellet, as a consequence of centrifugation. 
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Figure 4.27. Size distribution of 13 and 42 nm AuNP-MUA conjugated with BSA in a protein:AuNP molar ratio 
of 10000:1, uncentrifuged to bear the soft corona (SC) and centrifuged to expose the hard corona (HC). 
 
 
Figure 4.28. Size distribution of 13 and 42 nm AuNP-MUA conjugated with HSA in a protein:AuNP molar ratio 
of 10000:1, uncentrifuged to bear the soft corona (SC) and centrifuged to expose the hard corona (HC). 
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Figure 4.29. Size distribution of 13 and 42 nm AuNP-MUA conjugated with BPF in a protein:AuNP molar ratio 
of 200:1, uncentrifuged to bear the soft corona (SC) and centrifuged to expose the hard corona (HC). 
 
 
Figure 4.30. Size distribution of 13 and 42 nm AuNP-MUA conjugated with HPF in a protein:AuNP molar ratio 
of 200:1, uncentrifuged to bear the soft corona (SC) and centrifuged to expose the hard corona (HC). 
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Figure 4.31. Soft corona (SC) and hard corona (HC) hydrodynamic diameter comparison between 13 and 42 nm 
AuNP-MUA samples conjugated with a purposely excessive amount of BSA, HSA, BPF and HPF. 
 
This study was furthered for these conjugates with different protein:AuNP ratios and the 42 nm 
AuNP, as these not only produced better results with both fibrinogens, but also generated sharper curves 
with lower polydispersity for both serum albumins. 
Only the BPF conjugates exhibited the theoretically expected profile (figures 4.32 to 4.36), with 
the hydrodynamic diameter increasing after centrifugation merely for the conjugate sample with the 
lowest protein:AuNP ratio of 2:1, which could be explained by an incomplete coverage of the surface 
of AuNP, thus rendering these prone to aggregation during centrifugation; whereas it decreased as more 
protein was added, allowing the full formation of the innermost hard corona, before the soft corona can 
begin to assemble. As for the conjugates with the other proteins, it is still unclear why the hydrodynamic 
diameters systematically increased after centrifugation, other than due to aggregation. Another possible 
explanation is that a hard corona is actually impossible to achieve with MUA-functionalized AuNP due 
to proteins not binding strongly enough with the negatively charge surface as with a positively charged 
surface.68 In this case, only a soft corona would be formed, which centrifugation removed to expose the 
bare AuNP, more prone to centrifugation-induced aggregation. 
The graphs shown in figures 4.32 to 4.35 were generated through a Python script created by Prof. 
Ludwig Krippahl. 
Supplemental data with z-average and polydispersity index values can be found in Appendix IV, 
table IV.2. 
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Figure 4.32. Size distribution of 42 nm AuNP-MUA conjugated with BSA in the increasing protein:AuNP ratios 
of 20:1, 40:1, 60:1, 80:1 and 100:1; of soft corona and hard corona. 
 
 
Figure 4.33. Size distribution of 42 nm AuNP-MUA conjugated with HSA in the increasing protein:AuNP ratios 
of 20:1, 40:1, 60:1, 80:1 and 100:1; of soft corona and hard corona. 
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Figure 4.34. Size distribution of 42 nm AuNP-MUA conjugated with BPF in the increasing protein:AuNP ratios 
of 2:1, 4:1, 6:1, 8:1 and 10:1; of soft corona and hard corona. 
 
 
Figure 4.35. Size distribution of 42 nm AuNP-MUA conjugated with HPF in the increasing protein:AuNP ratios 
of 2:1, 4:1, 6:1, 8:1 and 10:1; of soft corona and hard corona. 
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Figure 4.36. Soft corona (SC) and hard corona (HC) hydrodynamic diameter comparison of 42 nm AuNP-MUA 
samples conjugated with BSA, HSA, BPF and HPF in increasing protein:AuNP ratios. 
 
4.6 Agarose gel electrophoretic assays 
Electrophoretic mobility profiling was useful for a detailed characterisation of AuNP conjugates 
with the different studied proteins, as through AGE assays with samples of an increasing protein:AuNP 
molar ratio it was possible to not only perceive the amount of each protein required for a full coverage 
of the surface of AuNP from the resulting conjugation curve, but also estimate the binding constant of 
these to the functionalized AuNP-MUA. 
First, an AGE assay was performed for AuNP conjugates with BSA in the protein:AuNP molar 
ratios of 10:1 to 100:1 in intervals of 10:1; and then until 500:1 in intervals of 100:1. Electrophoresis 
run times varied between 20 or 30 minutes, in order to achieve the maximum possible gel image quality, 
as shorter runs resulted in more imperceptible band mobility differences, but longer runs increased band 
smearing. For this assay, a run of 20 minutes was sufficient for the intended purpose (figure 4.37). 
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Figure 4.37. AGE bands of 13 nm AuNP-MUA at 2 nM conjugated with BSA in different protein:AuNP molar 
ratios, after a run of 20 minutes. 
 
This agarose gel image was subsequently processed through the eReuss software, which allowed 
for an accurate measurement of the distance travelled by each band through the gel and, from this data, 
the difference in electrophoretic mobility relative to the unconjugated AuNP-MUA was calculated and 
plotted against the BSA concentration in each sample (figure 4.38). The Hill-Langmuir equation could 
be fitted to the resulting curve, with an R2 = 0.979, which yielded a maximum electrophoretic mobility 
difference, Δµmax = 6.96 x 10-9 m2V-1s-1 and a binding constant, Ka = 9.01 x 10-3. It should be noted that, 
despite the Langmuir adsorption model having the best fitting to the electrophoretic mobility difference 
profiles, it assumes the initial protein concentration as the free protein concentration over time and that 
the loss of electrophoretic mobility is linearly proportional to AuNP surface occupancy. These are both 
inaccurate assumptions and, therefore, translate into some degree of error for the approximated binding 
constants. For this same reason, approximation artefacts affect the Hill coefficient calculation to an even 
greater extent, thus leading to erroneous assumptions of the degree of binding cooperativity. 
Moreover, the BSA:AuNP ratio of 70:1 appeared to be the first point in a scaffold towards which 
the conjugation curve developed, possibly marking the BSA:AuNP ratio at which the surface of AuNP 
is entirely covered with the protein, meaning more BSA added beyond this point would form secondary 
protein layers (soft corona) above the innermost monolayer (hard corona).  
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Figure 4.38. eReuss rendering of the band migration profiles for the above AGE image of a AuNP-BSA conjugates 
run of 20 minutes (left) and respective plot of the electrophoretic mobility difference relative to the unconjugated 
sample in dependence of protein concentration (right), fitted to a Hill-Langmuir equation. 
 
The same procedure was repeated for AuNP conjugates with the other studied proteins. As HSA 
exhibited great structural and chemical similarities to its bovine counterpart in the previous studies, the 
same protein:AuNP molar ratios were used and an electrophoretic run of 20 minutes was also sufficient 
for a good image quality (figure 4.39). 
A Hill-Langmuir fitting (figure 4.40), with an R2 = 0.979, resulted in a maximum electrophoretic 
mobility difference, Δµmax = 2.45 x 10-9 m2V-1s-1 and a binding constant, Ka = 7.76 x 10-2. Interestingly, 
despite the similarities found between both serum albumin counterparts in the preceding studies, AuNP 
conjugates with either protein exhibited different electrophoretic mobility profiles, namely the fact that 
a lower amount of HSA was required for completing the hard corona, with the first point of the scaffold 
at a HSA:AuNP ratio of 20:1; and that the binding constant calculated for HSA was higher than BSA. 
 
 
Figure 4.39. AGE bands of 13 nm AuNP-MUA at 2 nM conjugated with HSA in different protein:AuNP molar 
ratios, after a run of 20 minutes. 
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Figure 4.40. eReuss rendering of the band migration profiles for the above AGE image of a AuNP-HSA conjugates 
run of 20 minutes (left) and respective plot of the electrophoretic mobility difference relative to the unconjugated 
sample in dependence of protein concentration (right), fitted to a Hill-Langmuir equation. 
 
As fibrinogens are much larger proteins than serum albumins, a conjugation curve was expected 
at a lower protein:AuNP ratio range. An AGE assay was conducted for AuNP-BPF conjugates in ratios 
from 2:1 to 10:1 in intervals of 2:1, then 20:1 and 300:1, the latter used to test the profile of a sample 
saturated with fibrinogen; and performed on the same gel, side by side, with AuNP-BSA conjugates for 
a conjugation curve reference (figure 4.41). 
Contrary to BSA or HSA, BPF displayed three bands per lane on the lowest protein:AuNP ratios, 
which appear to blend with the topmost band as more protein is added – evidenced by the eReuss graph 
detecting dimmer band colour intensity peaks shifting to the top position (figure 4.42). One possible 
explanation to this phenomenon is that, at lower protein:AuNP ratios, in which the amount of protein is 
insufficient to completely cover the surface of all AuNP present, several populations of AuNP with a 
different number of adsorbed proteins form – only the difference in electrophoretic mobility imparted 
by one more or one less serum albumin to the AuNP is so negligible that these populations blend in a 
single band. However, for BPF, because of its larger dimensions, this difference in the electrophoretic 
mobility imparted by a difference of one protein to the AuNP is much more noticeable, hence the greater 
number of bands. 
The Hill-Langmuir equation could only be fitted to the topmost bands, with an R2 = 0.993, which 
resulted in a Δµmax = 1.43 x 10-8 m2V-1s-1 and a binding constant, Ka = 3.48. 
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Figure 4.41. AGE bands corresponding to 13 nm AuNP-MUA 2 nM conjugated with BSA (left) and BPF (right) 
in different protein:AuNP molar ratios, after a run of 20 minutes. 
 
 
Figure 4.42. Band migration profiles for the above AGE image of a AuNP-BSA (top left) and AuNP-BPF (top 
right) conjugates run of 20 minutes and plotted electrophoretic mobility difference relative to the unconjugated 
sample against protein concentration for the BPF conjugates (bottom), with a Hill-Langmuir fitting to the top 
bands. 
 
An AGE assay was performed for AuNP conjugates with HPF in a narrower protein:AuNP ratio 
range of 1:1 to 10:1 in intervals of 1:1, then to 25:1 in intervals of 5:1 (figure 4.43). 
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Similarly to its bovine counterpart, three bands were observed for HPF (figure 4.44), albeit the 
two lowermost rows of bands were still quite visible for the highest protein:AuNP ratios, which was 
not true in the BPF AGE assay. This allowed to detect another phenomenon, as the colour intensity of 
the lowermost bands appears to gradually decrease, whilst that of the topmost bands increases, which 
suggests a theoretically expected shift in the population number of AuNP bound to more proteins as 
more of the latter are added. 
The Hill-Langmuir equation could only be fitted to the two lowermost rows of bands. 
The fitting for the middle bands, with an R2 = 0.998, yielded a Δµmax = 9.35 x 10-9 m2V-1s-1 and 
a binding constant, Ka = 335.95. 
The fitting for the bottom bands, with an R2 = 0.902, yielded a Δµmax = 5.43 x 10-10 m2V-1s-1 and 
a binding constant, Ka = 2.34 x 10-1. 
 
 
Figure 4.43. AGE bands corresponding to 13 nm AuNP-MUA 2 nM conjugated with HPF in different 
protein:AuNP molar ratios, after a run of 20 minutes. 
 
 
Figure 4.44. eReuss rendering of the band migration profiles for the above AGE image of a AuNP-HPF conjugates 
run of 20 minutes (left) and respective plot of the electrophoretic mobility difference relative to the unconjugated 
sample in dependence of protein concentration (right), fitted to a Hill-Langmuir equation. 
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The differences in the electrophoretic mobility profiles and binding constants between conjugates 
of smaller, 13 nm AuNP and larger, 40 nm AuNP were evaluated using BSA conjugates as a reference, 
which required higher protein:AuNP ratios in order to cover the entire surface of these AuNP, given the 
greater surface area. For this, a stock of 40 nm AuNP-MUA was kindly provided by Miguel Peixoto de 
Almeida, PhD. These larger conjugates migrate more slowly in the agarose gel, thus an electrophoretic 
run of 30 minutes was necessary for obtaining a better image with discernible band mobility differences 
(figure 4.45). 
With an R2 = 0.957, a Hill-Langmuir fitting (figure 4.46) yielded a Δµmax = 6.66 x 10-9 m2V-1s-1, 
which is highly similar to that estimated for the smaller 13 nm AuNP conjugates (6.96 x 10-9 m2V-1s-1); 
and a binding constant of 3.77 x 10-3, lower than that of the 13 nm AuNP conjugates (9.01 x 10-3). 
 
 
Figure 4.45. AGE bands corresponding to 40 nm AuNP-MUA 0.1 nM conjugated with different BSA:AuNP 
ratios, after a run of 30 minutes. 
 
 
Figure 4.46. eReuss band migration profiles for the above AGE image of 40 nm AuNP conjugates with increasing 
BSA:AuNP ratios (left) and respective plot of the electrophoretic mobility difference relative to the unconjugated 
sample against protein concentration (right), fitted to a Hill-Langmuir equation. 
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The assessment of putative electrophoretic mobility differences between the soft and hard protein 
coronas was attempted through AGE assays, by preparing exact duplicates of 13 nm AuNP-MUA 2 nM 
conjugates samples with increasing BSA:AuNP molar ratios and centrifuging one of each pair, therefore 
assuming the uncentrifuged sample as the soft corona one and vice-versa. However, since the conjugates 
samples required a concentration step prior to loading in the gel, lest the bands would not be observable, 
yet having the AuNP-MUA concentrated before conjugation rendered conjugates unstable and prone to 
aggregate upon any further centrifugations, a compromise was found by resuspending the unconjugated 
AuNP-MUA pellets, after the centrifugation to remove excess capping agent, in different final volumes 
for each pair. Thus, the soft corona samples, which would not be submitted to a second centrifugation, 
were resuspended in one tenth of the discarded supernatant volume, resulting in an approximate final 
concentration of 20 nM, whereas the hard corona ones were resuspended in an identical volume. After 
the conjugation procedure, the latter were centrifuged to remove the soft corona and resuspended in one 
tenth of the discarded supernatant volume, matching the final concentration of the former (figures 4.47 
and 4.48). 
 
 
Figure 4.47. AGE bands corresponding to 13 nm AuNP-MUA conjugates in increasing BSA:AuNP ratios, in 
which, for every pair with the same ratio, the left and right bands correspond to uncentrifuged and centrifuged 
samples, of assumed soft corona (SC) and hard corona (HC), respectively.  
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Figure 4.48. eReuss band migration profile for the above AGE image of soft and hard corona AuNP-BSA 
conjugates (left) and respective electrophoretic mobility difference relative to AuNP-MUA plotted in dependence 
of protein concentration (right) for the uncentrifuged samples, in red; and the centrifuged ones, in blue. 
 
In order to test if this electrophoretic mobility variance observed between AuNP-BSA conjugates 
with identical protein:AuNP ratios was due to the removal of the soft corona through centrifugation or 
to another phenomenon derived from the conditions in which the samples were prepared, an AGE assay 
was devised to eliminate the possibility of protein corona interference. 
Aliquots of 13 nm AuNP-MUA 2 nM were centrifuged once to remove excess capping agent and 
subsequently resuspended in different volumes prior to a conjugation procedure with BSA, as described 
in table 4.8, after which all samples were made up to an identical volume and immediately centrifuged 
a second time.  
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Table 4.8. Final colloidal suspension volumes in which conjugation occurred for the BSA:AuNP ratios described. 
Sample AuNP volume (µL) BSA:AuNP ratio 
1 - 0:1 
2 50 
20:1 
3 500 
4 50 
40:1 
5 500 
6 50 
60:1 
7 500 
8 50 
80:1 
9 500 
10 50 
100:1 
11 500 
12 50 
200:1 
13 500 
14 50 
300:1 
15 500 
 
Based on the results (figures 4.49 and 4.50), the previous assumption that the variances observed 
in the electrophoretic mobility of uncentrifuged and centrifuged AuNP-BSA conjugates in the preceding 
AGE assay were due to the pairs of samples bearing a soft and hard corona, respectively, was reassessed, 
for identical results were obtained with the centrifugation of all samples. 
Moreover, the electric field applied during the electrophoresis may interfere with the electrostatic 
interactions amongst the more loosely bound soft corona proteins, causing the detachment of these from 
the AuNP, which would make electrophoresis a protein corona separation method, at the minimum, as 
effective as centrifugation, thus precluding the visualisation of the soft and hard corona. 
However, this AGE assay also revealed an overlooked phenomenon occurring in the conjugation 
process, in which the AuNP colloidal suspension volume appears to affect conjugation efficiency, given 
the electrophoretic mobility variances observed between samples conjugated in identical protein:AuNP 
ratios, but different AuNP volumes. 
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Figure 4.49. AGE bands corresponding to 13 nm AuNP-MUA conjugates in increasing BSA:AuNP ratios, in 
which, for every pair with the same ratio, the left and right bands were conjugated in the colloidal suspension 
volumes of 50 and 500 µL, respectively, with subsequent centrifugation for all samples. 
 
 
Figure 4.50. eReuss band migration profiling for the AGE image of AuNP-BSA samples conjugated in two 
different colloidal suspension volumes (left) and respective electrophoretic mobility difference relative to the 
unconjugated AuNP-MUA plotted against protein concentration (right) for the samples conjugated in 50 µL (red) 
and the ones conjugated in 500 µL (blue). 
 
In order to verify if this phenomenon occurs with AuNP-MUA conjugated with the other studied 
proteins, a similar AGE assay was devised, with samples prepared as described in table 4.9. A complete 
surface coverage of the AuNP was intended, thus the selected protein:AuNP ratios were purposely high.  
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Table 4.9. Final colloidal suspension volumes in which conjugation with BSA, HSA, BPF or HPF occurred for 
the protein:AuNP ratios described. 
Sample Protein Protein:AuNP ratio AuNP volume (µL) 
1 - 0:1 - 
2 
BSA 
1000:1 
500 
3 50 
4 10 
5 
HSA 
500 
6 50 
7 10 
8 
BPF 
200:1 
500 
9 50 
10 10 
11 
HPF 
500 
12 50 
13 10 
 
After the conjugation procedure, all samples were adjusted to a final volume of 500 µL prior to 
the required concentration step through centrifugation, in order to have more perceptible bands. A first 
gel image was taken after an electrophoretic run of 20 minutes (figure 4.51). 
 
 
Figure 4.51. AGE bands of unconjugated AuNP-MUA and AuNP-MUA conjugated with BSA, HSA, BPF and 
HPF in purposely high protein:AuNP ratios, each protein conjugated in colloidal suspension volumes of 500, 50 
and 10 µL, after an electrophoretic run of 20 minutes (left); and corresponding eReuss band migration profiling 
(right).  
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Although electrophoretic mobility variances were already visible between the different volumes 
for the BSA conjugates, this phenomenon was not perceptible on the conjugates with the other proteins, 
therefore – and to further accentuate these variances – the gel was submitted to an additional 10 minutes 
of electrophoretic run, at the cost of increased band smearing (figure 4.52). 
Comparing first the electrophoretic mobility profiles between the different proteins, there were 
some interesting divergences, namely the fact that the human variant of serum albumin migrated further 
than its bovine counterpart, yet the opposite occurred with the fibrinogens. Given the great proximity 
between the molecular weights of bovine and human counterparts for each protein, these discrepancies 
may indicate a different a number of AuNP binding sites on the surfaces of these proteins, allowing the 
adsorption to more than one AuNP per protein. 
By analysing, for each protein, the profiles between the samples conjugated in different volumes, 
there is a distinctive influence of colloidal suspension volume over conjugation efficiency only for BSA, 
as this phenomenon was not observed with the other proteins. This could be explained if the structure 
of BSA compresses in such way under the steric pressure of more concentrated mediums that it allows 
for more to fit on the surface of a AuNP, albeit this does not happen with the other proteins. 
 
 
Figure 4.52. AGE bands of unconjugated AuNP-MUA and conjugated with BSA, HSA, BPF and HPF in 
purposely high protein:AuNP ratios, each protein conjugated in colloidal suspension volumes of 500, 50 and 10 
µL, after an electrophoretic run of 30 minutes (left); and corresponding eReuss band migration profiling (right). 
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To further study this effect, a series of AGE assays were realised using various BSA:AuNP ratios 
each, with samples conjugated in different AuNP colloidal suspension volumes. For each assay, aliquots 
of 12 nm AuNP-MUA 1.5 nM were resuspended in final colloidal suspension volumes of 10 to 100 µL 
in intervals of 10 µL, then to 500 µL in intervals of 100 µL, after the centrifugation to remove excess 
capping agent; and subsequently conjugated with BSA in the same protein:AuNP ratio per assay, all of 
which are summarised in table 4.10. Good gel quality was achieved for all assays with an electrophoretic 
run of 20 minutes (figures 4.53 to 4.57). 
 
Table 4.10. Preparation of samples for the AGE assay series, with varying AuNP colloidal suspension volumes 
and conjugated with the same BSA:AuNP ratio for each assay. 
Sample AuNP volume (µL) 
BSA:AuNP ratio 
Assay 1 Assay 2 Assay 3 Assay 4 Assay 5 
1 - 0:1 0:1 0:1 0:1 0:1 
2 10 
20:1 40:1 60:1 80:1 100:1 
3 20 
4 30 
5 40 
6 50 
7 60 
8 70 
9 80 
10 90 
11 100 
12 200 
13 300 
14 400 
15 500 
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Figure 4.53. AGE bands of unconjugated AuNP-MUA and conjugated in a BSA:AuNP ratio of 20:1, in increasing 
colloidal suspension volumes (left); and corresponding eReuss band migration profiling (right). 
 
 
Figure 4.54. AGE bands of unconjugated AuNP-MUA and conjugated in a BSA:AuNP ratio of 40:1, in increasing 
colloidal suspension volumes (left); and corresponding eReuss band migration profiling (right). 
 
 
Figure 4.55. AGE bands of unconjugated AuNP-MUA and conjugated in a BSA:AuNP ratio of 60:1, in increasing 
colloidal suspension volumes (left); and corresponding eReuss band migration profiling (right). 
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Figure 4.56. AGE bands of unconjugated AuNP-MUA and conjugated in a BSA:AuNP ratio of 80:1, in increasing 
colloidal suspension volumes (left); and corresponding eReuss band migration profiling (right). 
 
 
Figure 4.57. AGE bands of unconjugated AuNP-MUA and conjugated in a BSA:AuNP ratio of 100:1, in 
increasing colloidal suspension volumes (left); and corresponding eReuss band migration profiling (right). 
 
The electrophoretic mobility difference relative to the unconjugated AuNP-MUA for the samples 
of each assay was plotted against the respective protein concentrations (figure 4.58). 
For the BSA:AuNP molar ratios ≤ 60:1, conjugation was most efficient, as observed in the peaks 
of highest electrophoretic mobility difference in figure 4.58, at higher colloidal suspension volumes, in 
which the protein concentration is lower (< 1000 nM); whereas, for 80:1 and 100:1, conjugation appears 
more efficiency as protein concentration increases. 
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Since the conjugation curve for BSA reached an apparent scaffold at the protein:AuNP of 70:1, 
which was assumed as the required amount of this protein for a full hard corona monolayer formation, 
it is possible that the increased concentration of both AuNP and BSA – consequent of the decreased 
colloidal suspension volume during conjugation – would induce steric hindrance on the adsorption 
process with an insufficient amount of protein to cover the entire surface of a AuNP, which is surpassed 
as more protein is added. Beyond this point, the formation of the soft corona multilayers would be 
enhanced in environments of more concentrated AuNP and BSA. This prompts to the fact that the 
adsorption process is not a complete reaction and tends towards a thermodynamic equilibrium with 
populations of adsorbed protein as well as of unbound, free protein. 
 
 
Figure 4.58. Profiles of relative electrophoretic mobility difference in dependence of protein concentration for 
each of the above AGE assays. 
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5 Conclusions and future perspectives 
The studied proteins – both bovine and human counterparts of serum albumin (BSA and HSA, 
respectively) and fibrinogen (BPF and HPF, respectively) – were compared for sequential and structural 
homology. Gold nanoparticles (AuNP) functionalized with 11-mercaptoundecanoic acid (MUA) were 
successfully conjugated with each of the studied proteins. These single protein conjugates were studied 
for colloidal stability with varying ionic strength and pH, for protein conformational alterations through 
circular dichroism spectroscopy, for protein corona hydrodynamic diameter variations through dynamic 
light scattering and for electrophoretic mobility differences through agarose gel electrophoresis. 
Both bovine and human counterparts of serum albumin and fibrinogen scored high sequential and 
structural homology, although the fibrinogen conjugates differed slightly in colloidal stability with ionic 
strength variation. However, in varying pH, all respective counterparts displayed quite similar colloidal 
stability patterns, with the gold nanoparticle conjugates withholding from irreversible aggregation until 
a less acidic microenvironment than unfunctionalized AuNP-citrate or even unconjugated AuNP-MUA. 
Moreover, comparatively to AuNP-citrate, AuNP-MUA is more advantageous as, besides the increment 
in stability and biocompatibility, the unconjugated gold nanoparticles would not migrate in agarose gel 
electrophoresis, making it impossible to estimate the binding constants by a Hill-Langmuir fitting to the 
conjugation curve. 
The secondary structure of BSA and HSA underwent noticeable conformational alterations once 
adsorbed to the surface of AuNP, confirming a loss in α-helix density. Due to technical limitations of 
circular dichroism spectroscopy, these same measurements could not be performed for the fibrinogen 
conjugates. Alternatively, in the future, the secondary structure of proteins integrating the protein 
corona formed on a AuNP could be studied through Fourier transform infrared spectroscopy (FTIR) or 
nuclear magnetic resonance (NMR).89 
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Centrifugation was demonstrated to remove the soft corona, albeit with a high tendency of inducing 
irreversible nanoparticle aggregation. A decrease in hydrodynamic diameter for centrifuged conjugates 
samples was best observed for either serum albumin counterpart conjugated to 13 nm gold nanoparticles 
and for either fibrinogen conjugated to 42 nm gold nanoparticles. Furthermore, conjugates samples were 
less prone to aggregate upon centrifugation at protein:AuNP molar ratios higher than those determined, 
for each protein, as the minimum required to guarantee a complete coverage of the nanoparticle surface, 
which could be visualised in the conjugation curves exhibited in the agarose gel electrophoretic assays. 
For the future, the separation of soft and hard corona samples could be performed through asymmetrical 
flow field flow fractionation (AF4), which some studies have reported being more accurate in separating 
such samples, whilst much less aggressive than centrifugation, hence minimising risk of aggregation.90 
Additionally, the information provided by the hydrodynamic radius of conjugates with different protein 
coronas could be complemented by determining the radius of gyration, which can be measured through 
either multi-angle dynamic light scattering (MADLS), static light scattering (SLS) or small angle X-ray 
scattering (SAXS) and the ratio of which to the hydrodynamic radius is indicative of how compact the 
nanoparticles and the complexes formed with proteins are.51 
Electrophoretic assays revealed the amount of HSA necessary to fully cover one gold nanoparticle 
is lower than that of its bovine counterpart, which could indicate both assume different orientations 
upon adsorbing to the nanoparticle surface. Assuming the Hill-Langmuir equation as the best fitting to 
the conjugation curves, further differences were discovered between respective protein counterparts, 
considering distinct binding constants were calculated (9.01 x 10-3 for BSA, 7.76 x 10-2 for HSA, 3.48 
for BPF and 2.34 x 10-1 for HPF). Despite this, the binding constants for either serum albumin were 
much smaller than those of fibrinogen, which is in accordance with the Vroman effect, which states that 
fibrinogen possesses a higher affinity to surfaces than serum albumin. Discrepancies in the binding 
constants were also found for the same protein conjugated to gold nanoparticles with a different size. 
Moreover, colloidal gold suspension volume was determined to be an important factor for conjugation 
efficiency, as it was promoted at lower volumes, provided the amount of free protein available was 
sufficient to complete the formation of the first protein corona monolayer, or hard corona. 
Finally, these experiments are to be performed on the other human blood plasma proteins, namely 
the globulins, including numerous proteins of various shapes and sizes and different affinities to AuNP. 
Furthermore, these experiments are also to be conducted on AuNP conjugates of more than one plasma 
protein, added at different times and varying the order, thus testing protein competition, as described 
by the Vroman effect. This is important, as AuNP biosensors would be exposed to whole blood samples 
and, therefore, the protein corona profiles would also vary with time, with proteins of lower abundance 
but higher affinity replacing the more abundant ones comprising the initial coronas. 
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Appendix 
I. Techniques 
I.1 Circular dichroism 
An important part of understanding the behaviour of proteins as these integrate the protein corona 
is to detect conformational alterations upon adsorption to the surface of nanoparticles. For this purpose, 
circular dichroism (CD) has been a valuable technique in structural biology, which allows to determine 
the secondary structure of proteins in solution, as these are generally found. A CD signal arises with the 
absorption of circularly polarised radiation by chiral molecules, of which proteins possess various chiral 
chromophores, namely aromatic amino acid chains, which absorb in the 320-260 nm wavelength range; 
disulphide bonds, which absorb at approximately 260 nm; or peptide bonds, absorbing below 240 nm.85 
The measured circularly polarised radiation corresponds to the differential absorbance between left and 
right circularly polarised radiation, respectively oriented counter-clockwise and clockwise, as described 
in the equation: 
 
 𝛥𝐴 = 𝐴𝐿 − 𝐴𝑅 Equation I.1 
 
If the amplitudes of both left and right circularly polarised radiation components are not identical, 
the combined radiation is elliptically polarised (figure I.1. AII), hence CD spectra are typically reported 
as ellipticity, θ and measured in degrees.85 The ellipticity can be calculated from the circularly polarised 
radiation differential absorbance: 
 
 𝜃 = 32.98𝛥𝐴 = tan−1
𝑏
𝑎
 Equation I.2 
 
b and a are the minor and major axes of the resulting ellipse, respectively. 
 
 
Figure I.1. Left (L) and right (R) circularly polarised light combine to generate plane polarised radiation if both 
have the same amplitude (AI); or elliptically polarised radiation if both have different amplitudes (AII). CD spectra 
bands coincide with UV-Vis absorption spectra ones, although these can be positive if L is absorbed more than R 
(B1), negative if R is absorbed more than L (B2) or null in achiral chromophores (B3). Adapted from 85. 
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CD spectra of proteins are typically measured in the far UV wavelength range, considering most 
protein chiral chromophores absorb in this region, as previously mentioned, as well as the fact that CD 
measurements in the far UV provide quantitative secondary structure estimates which can be compared 
to those from X-ray crystallography or nuclear magnetic resonance (figure I.2). Additionally, CD data 
acquired in the near UV or visible wavelengths require a much higher and more limited range of sample 
concentration.85 
 
 
Figure I.2. CD spectra of prevalent protein secondary structures: α-helix (solid line), β-sheet (long dashed line), 
β-turn (dotted line), polyproline helix (cross dashed line) and random coil (short dashed line). Adapted from 85. 
 
Since AuNP are achiral structures and thus do not exhibit chiroptical properties, these should not 
cause interference in the CD spectra of adsorbed proteins. Nevertheless, some noise in these spectra has 
been attributed to bare AuNP, which is assumed to be due to the circularly polarised radiation interacting 
with the electromagnetic field generated from the gold surface. However, this effect is diminished if all 
AuNP are properly coated with protein, as the incident circularly polarised radiation is modulated solely 
by the outermost molecules in a complex.84–86,91  
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I.2 Dynamic light scattering 
One simple approach to characterise a complex formed of plasma proteins adsorbed to the surface 
of AuNP is the measurement of its increase in diameter, through which the surface density of conjugated 
molecules can be quantified, whilst also providing information on nanoparticle aggregation and protein 
compactness, thus hinting at conformational alterations.11 Dynamic light scattering (DLS) is a technique 
which allows to estimate the size of solvated particles at the nanoscale based on how these scatter light 
from an incident laser, requiring low sample concentrations and yielding robust data on size distribution 
and polydispersity index (PDI). Transmission electron microscopy (TEM) can also be used for the same 
purpose, although samples cannot be measured in solution and must be thoroughly dried – thus making 
for a more extensive sample preparation procedure – whereas DLS can even measure a greater number 
of particles than this technique, therefore producing more reliable size distribution data.51 Nanoparticle 
tracking analysis (NTA) is another alternative technique to DLS which is also based on light scattering. 
Both techniques estimate particle size from the diffusion coefficient, which DLS detects by correlating 
the scattered light intensity fluctuations over time, whereas NTA detects it by recording the mobility of 
diffusing particles based on the light these scatter, using charged-couple device cameras. Despite being 
slightly less prone to calculated particle size error than DLS, NTA is less capable of detecting particles 
smaller than 30 nm, besides being more complex and expensive.51 
DLS measures the hydrodynamic diameter of suspended particles – the diameter of a hypothetical 
hard sphere of identical diffusion velocity – as these are in a constant motion due to density fluctuations 
in the colloidal suspension, known as Brownian motion. Light from an incident monochromatic laser is 
scattered by the dipoles formed from the oscillating electric fields of sampled particles, which originate 
from the interaction with the electric field of the incident light, as previously discussed. Scattered light 
can be shifted to different frequencies depending on particle diffusion velocity and direction relative to 
the detector, as per the Doppler effect. Moreover, if the particles are smaller than a tenth of the incident 
light wavelength, the scattered light is not angle dependent and its energy is conserved, which describes 
an elastic Rayleigh scattering; otherwise the anisotropic, quasi-elastic Mie scattering is observed (figure 
I.3). 
 
 
Figure I.3. Differences between Rayleigh and Mie scattering.51 
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As several particles diffuse continuously through the medium and the incident laser, constructive 
and destructive interferences are detected on the scattered light intensity over time. These scattered light 
intensity fluctuations are thus correlated against short decay intervals, τ and an intensity auto-correlation 
function (ACF), G can be obtained through the following equation: 
 
 𝐺(𝜏) = 1 + 𝑏𝑒−2𝐷𝑡𝑞
2𝜏 Equation I.3 
 
b is a constant dependent on the DLS instrument and optical settings, Dt the translational diffusion 
coefficient – obtained through the Stokes-Einstein equation – and q the scattering vector, which can be 
expressed as: 
 
 𝐷𝑡 =
𝑘𝐵𝑇
6𝜋𝜂𝑅𝐻
 Equation I.4 
 
 |𝑞| =
4𝜋𝑛0
𝜆0 sin
𝜃
2
 Equation I.5 
 
kB is the Boltzmann constant, T the temperature, η the dispersant viscosity, RH the hydrodynamic 
radius, n0 the solvent refractive index, λ0 the laser wavelength in vacuum and θ the scattering angle. The 
PDI corresponds to the calculated particle hydrodynamic diameter for each scattered light intensity peak 
measured over time divided by the mean. Sampled particles with a PDI < 0.1 can be considered virtually 
monodisperse, whilst a PDI of 0.1-0.4 or > 0.4 indicates moderate and high polydispersity, respectively. 
In sufficiently polydisperse samples, larger particles scatter light with much more intensity than smaller 
ones – given the scattered light intensity is proportional to the sixth power of the particle hydrodynamic 
radius – thus compromising an accurate size estimation for the entire population, as the smaller particles 
go undetected. Additionally, too concentrated samples can also induce such measurement imprecisions, 
since the light scattered by one particle has a greater probability to be scattered again by another in close 
proximity, therefore producing erroneous results which can even mislead the instrument into assuming 
a cluster of neighbouring smaller particles as a single larger one. Despite these issues related to samples, 
one limitation inherent to this technique is its relatively low resolution, as it can only distinguish particle 
sizes differing by a minimum factor of three (for example, 10 and 30 nm, or 50 and 150 nm), considering 
anything below this threshold as one single broad peak, instead of two individual peaks.51,92  
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I.3 Electrophoresis 
Suspended molecules such as nanoparticles or proteins – or complexes formed of both – possess 
an electric surface charge and thus migrate in solution as an external electric field is applied. This effect 
is exploited in various electrophoretic techniques for the separation of such suspended molecules based 
on charge and, in the specific case of gel electrophoresis, shape, size and molecular weight, as these are 
forced to migrate through the pores of the gel. Considering null molecular dynamics in the course of an 
electrophoretic assay, meaning no chemical reactions occur amongst the sampled molecules, molecular 
dynamics occur at a uniform rate and with a constant migration ratio, which is influenced by the applied 
electric current, the shape, size and hydrophobicity of the molecules being separated, the ionic strength 
and viscosity of the solvent and the temperature.93 The electrophoretic mobility, µ can thus be calculated 
through the following equation: 
 
 µ =
𝜈
𝐸
=
𝑍
𝑓
 Equation I.6 
 
 𝑓 = 6𝜋𝜂𝑟 Equation I.6 
 
ν is the migration velocity, E the electric field strength, Z the total molecular charge, f the friction 
coefficient, η the medium viscosity and r the molecule radius. In a uniform electric field, E corresponds 
to the negative quotient of the electric potential difference, V and the distance separating the electrodes, 
d, which is expressed as: 
 
 𝐸 = −
𝑉
𝑑
 Equation I.7 
 
As the charged molecules under an electric field are driven towards the electrode of the opposite 
charge through an electrostatic coulombic force, the opposite occurs for counterions in solution, which 
can also integrate the diffuse layer of the sampled molecules, as previously discussed. The force applied 
onto the counterions in the diffuse layer of a molecule generates a drag – a retardation force – of which 
a part is transferred to the molecule surface by viscous stress (figure 1.19). The thickness of the EDL is 
directly proportional to the distance between the retardation force point of application and the molecule 
surface and, consequently, inversely proportional to the retardation force applied onto the molecule.94 
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Figure I.4. Electrophoretic flow of a positively charged particle.94 
 
Given the relationship between the EDL of a suspended molecule and its electrophoretic mobility 
(µ), its ζ-potential (ζ) can be obtained through Henry’s equation: 
 
 µ =
𝜀𝑟𝜀0𝜁
𝜂
𝑓(𝜅𝑟) Equation I.8 
 
 𝑓(𝜅𝑟) = {1 − 𝑒𝜅𝑟[5𝐸7(𝜅𝑟) − 2𝐸5(𝜅𝑟)]} Equation I.9 
 
εr is the relative permittivity of the solution, ε0 the permittivity of vacuum, η the solvent viscosity, 
f(κr) Henry’s function of the product of the Debye-Hückel parameter (κ) and the radius of the molecule 
(r) and En(κr) the exponential integral of order n. As the thickness of the EDL (κ-1) decreases, f(κr) tends 
to unity, as described by the Smoluchowski theory; conversely, for an EDL of infinite thickness, it tends 
to a value of 2/3, which corresponds to the Hückel approximation.93–96 
 
I.3.1 Agarose gel electrophoresis 
A common and simple technique used for the separation of biomolecules such as nucleic acids, 
proteins or nanoparticle-protein conjugates, agarose gel electrophoresis (AGE) has samples placed in a 
gel matrix of agarose and forced to migrate horizontally through the gel pores by an electric field applied 
from placing two electrodes of opposite charge on both extremities of the gel matrix (figure I.5). Sample 
migration is visualised by dying these either before or after an electrophoretic assay, although this is 
unnecessary for AuNP and its conjugates with protein, given the red colour characteristic to these 
nanoparticles. The porosity, viscosity and conductivity of the gel can be tuned by adjusting the buffer 
composition and agarose concentration, which is inversely proportional to pore size and, consequently, 
affects the size range of the molecules being separated.93 
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Figure I.5. Agarose gel electrophoresis system.93 
 
I.3.2 SDS-PAGE 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) is an 
electrophoretic technique based on a gel matrix, differing from AGE in that the gel is polymerised from 
acrylamide and bisacrylamide in the presence of the cross-linking agent ammonium persulphate, which 
yields a well-defined, well-structured matrix of more finely tuneable pore sizes and a higher molecular 
weight resolution comparatively to agarose. SDS-PAGE also requires two gels, one more concentrated 
for the separation of samples and another in which these are loaded and allowed to concentrate prior to 
applying the electric field, respectively denominated the resolving and stacking gels. Since two gels are 
required to polymerise atop one another, this results in a vertically oriented gel matrix (figure I.6).93 
The molecular weight of proteins can be determined through this technique. As proteins possess 
distinct surface electrostatic potentials and structural conformations, in order to have a separation based 
solely on molecular weight differences, these are typically denatured by the anionic detergent sodium 
dodecyl sulphate – hence the SDS part in SDS-PAGE, distinguishing it from a native PAGE – prior to 
the electrophoretic assay. This detergent imparts a uniform negative charge to the proteins, allowing 
separation to be based only on molecular weight. In SDS-PAGE, denatured proteins are fragmented 
into its component chains by using a thiol reducing agent such as β-mercaptoethanol. These denatured 
proteins assume an elongated form and acquire an evenly distributed negative surface charge.93 
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Figure I.6. Electrophoretic protein separation through SDS-PAGE.93  
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II. Reagents and instruments 
Reagents: 
11-mercaptoundecanoic acid, ≥ 95%, Sigma-Aldrich 
Absolute ethanol, HPLC grade, ≥ 99.9%, Carlo Erba 
Acrylamide/bis-acrylamide, 30% (w/v), Bio-Rad 
Agarose, low electroendosmosis, Sigma 
Ammonium persulfate (APS), ≥ 98%, Sigma-Aldrich 
Bicinchoninic acid solution, Supelco (Sigma-Aldrich) 
Bovine plasma fibrinogen, lyophilised powder, 65-85%, Sigma-Aldrich 
Bovine serum albumin protein standard, 1 mg/mL, ≥ 99.9%, Sigma-Aldrich 
Bovine serum albumin, lyophilised powder, ≥ 96%, Sigma-Aldrich 
Bromophenol blue, ≥ 99.5%, PanReac AppliChem 
Coomassie brilliant blue R-250, Sigma-Aldrich 
Copper(II) sulphate pentahydrate, ≥ 98.0%, Sigma-Aldrich 
Ethylenediaminetetraacetic acid (EDTA) 0.5 M, ≥ 98%, Honeywell Fluka 
Glacial acetic acid, 98.5%, Carlo Erba 
Glycerol, ≥ 99.5%, Sigma Aldrich 
Glycerol, 87%, PanReac AppliChem 
Glycine, ≥ 99%, Sigma 
Gold(III) chloride solution, ≥ 99.99%, 30% (w/w) in dilute HCl, Sigma-Aldrich 
Human plasma fibrinogen, lyophilised powder, 50-70%, Sigma-Aldrich 
Human serum albumin, lyophilised powder, ≥ 96%, Sigma-Aldrich 
Hydrochloric acid, ≥ 37%, Honeywell Fluka 
Methanol, ≥ 99.9%, Fisher Scientific 
Nitric acid, 65%, PanReac AppliChem 
Potassium phosphate dibasic, anhydrous, ≥ 98%, Sigma-Aldrich 
Potassium phosphate monobasic, anhydrous, ≥ 99%, Sigma-Aldrich 
Sodium chloride, ≥ 99.5%, Scharlau 
Sodium citrate tribasic dihydrate, ≥ 99.0%, Sigma-Aldrich 
Sodium dodecyl sulphate (SDS), ≥ 98.5%, Sigma Aldrich 
Sodium hydroxide, pellets (anhydrous), ≥ 98%, Sigma-Aldrich 
Tetramethylethylenediamine (TEMED), ≥ 99%, VWR Life Science AMRESCO 
Tris(hydroxymethyl)aminomethane, ≥ 99.5%, Carlo Erba 
Unstained low range SDS-PAGE standards, Bio-Rad 
β-mercaptoethanol, Sigma-Aldrich  
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Instruments: 
Bio-Rad Mini-PROTEAN Tetra Electrode Assembly 
Bio-Rad Mini-PROTEAN Tetra Vertical Electrophoresis Cell 
Bio-Rad Mini-Sub Cell GT 
Bio-Rad PowerPac Basic Power Supply 
Biosan TS-100 Thermo-Shaker 
Centurion Scientific K3 Series centrifuge, rotor BRK5424 
Chirascan qCD spectrometer 
Crison pH meter Basic 20+ 
Hellma quartz cuvette, 1 mm path length 
Hellma quartz cuvette, 10 mm path length 
HORIBA SZ-100 nanopartica analyser 
J.P. Selecta Agimatic-N magnetic stirrer with heating plate 
Macherey-Nagel pH-Fix 0-14 pH test strips 
RADWAG AS 220/C/2 analytical balance 
Sarstedt PMMS cuvettes, 4 openings 
Varian Cary 50 Bio UV-Vis spectrophotometer  
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III. Characterisation of gold nanoparticle 
Table III.1. Estimated molar extinction coefficients, ε at a wavelength of 450 nm for gold nanoparticles of a size, 
d ranging from 2 to 100 nm. 
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IV. Dynamic light scattering supplemental information 
Table IV.1. DLS hydrodynamic diameter data of 13 and 42 nm AuNP-MUA samples conjugated with a purposely 
excessive amount of BSA, HSA, BPF and HPF; of soft corona (SC) and hard corona (HC). 
Sample Peak mode (nm) Z-average (nm) Polydispersity index 
13 nm 
AuNP 
BSA 
SC 68.9 64.4 0.550 
HC 68.3 107.8 0.589 
HSA 
SC 32.9 181.2 0.535 
HC 25.9 147.2 0.557 
BPF 
SC 42.6 3095.4 6.287 
HC 77.7 4003.9 1.983 
HPF 
SC 56.2 2679.7 2.866 
HC 69.6 13596.3 2.713 
42 nm 
AuNP 
BSA 
SC 87.1 75.4 0.293 
HC 77.6 79.3 0.258 
HSA 
SC 68.2 62.2 0.221 
HC 77.9 82.6 0.184 
BPF 
SC 87.0 86.1 0.075 
HC 77.5 83.7 0.140 
HPF 
SC 87.1 82.9 0.29 
HC 87.2 87.8 0.123 
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Table IV.2. DLS hydrodynamic diameter data of 42 nm AuNP-MUA samples conjugated with BSA, HSA, BPF 
and HPF in increasing protein:AuNP ratios; of soft corona (SC) and hard corona (HC). 
Sample 
Peak mode (nm) Z-average (nm) Polydispersity index 
SC HC SC HC SC HC 
BSA-AuNP 
20:1 53.6 60.5 47.5 54.5 0.404 0.240 
40:1 53.6 60.4 49.1 54.1 0.208 0.230 
60:1 47.6 60.4 46.1 54.0 0.537 0.263 
80:1 53.6 60.5 47.8 56.7 0.293 0.174 
100:1 53.7 60.9 46.7 57.0 0.373 0.159 
HSA-AuNP 
20:1 53.6 60.5 49.1 54.2 0.247 0.274 
40:1 53.5 60.5 47.5 56.3 0.280 0.137 
60:1 47.7 60.5 48.0 55.3 0.179 0.244 
80:1 47.7 53.7 46.5 49.6 0.380 0.521 
100:1 53.5 60.8 48.3 57.1 0.303 0.293 
BPF-AuNP 
20:1 68.6 87.5 65.4 74.3 0.280 0.334 
40:1 99.5 98.4 81.5 82.0 0.278 0.280 
60:1 126.7 77.2 93.7 67.2 0.454 0.597 
80:1 99.1 60.6 95.8 395.1 0.394 0.825 
100:1 99.5 77.2 103.3 67.1 0.496 0.399 
HPF-AuNP 
20:1 60.8 68.7 58.8 64.3 0.170 0.304 
40:1 68.6 98.5 59.6 86.4 0.324 0.218 
60:1 68.5 77.3 62.1 70.7 0.343 0.500 
80:1 87.2 87.5 72.1 78.9 0.349 0.442 
100:1 87.4 87.3 89.6 84.6 0.423 0.359 
 
